| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynactin binding | 1.69e-05 | 12 | 279 | 4 | GO:0034452 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR NCOA6 AKAP8 TOX DHX9 ARID1B SALL1 NFATC2 ATXN1 YAP1 TAF2 DMRT1 DPPA2 AIRE MSL1 RUNX1 YBX2 MLH3 H1-6 TSPYL5 MBD5 HCFC1 VCX HELLS | 1.19e-04 | 739 | 279 | 24 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.71e-04 | 59 | 279 | 6 | GO:0001222 | |
| GeneOntologyBiologicalProcess | neuron development | NRG1 TOX MAPT LYPLA2 LRRK2 TTC36 CDH23 MPDZ ADGRV1 PCDH12 EPB41L3 DIP2A NEO1 ARID1B SERPINI1 NFE2L2 KDR DMD CACNA1A KIF13B HSPG2 FAT4 FN1 NRCAM FAT3 DDR2 APBB2 FRYL RUNX1 SHANK3 SCARF1 GRIP1 ARHGEF40 PAFAH1B1 LRP6 CNTN3 MACF1 ROBO2 BRSK1 CDH2 CDH4 HTT | 2.69e-06 | 1463 | 278 | 42 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | NRG1 TOX MAPT LRRK2 NEO1 SERPINI1 NFE2L2 DMD CACNA1A KIF13B FN1 NRCAM FAT3 DDR2 SHANK3 SCARF1 GRIP1 PAFAH1B1 LRP6 MACF1 ROBO2 BRSK1 CDH2 CDH4 | 3.18e-06 | 612 | 278 | 24 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron projection development | NRG1 TOX MAPT LYPLA2 LRRK2 CDH23 MPDZ ADGRV1 EPB41L3 DIP2A NEO1 ARID1B SERPINI1 NFE2L2 KDR DMD CACNA1A KIF13B HSPG2 FAT4 FN1 NRCAM FAT3 DDR2 APBB2 FRYL SHANK3 SCARF1 GRIP1 ARHGEF40 PAFAH1B1 LRP6 CNTN3 MACF1 ROBO2 BRSK1 CDH2 CDH4 | 4.32e-06 | 1285 | 278 | 38 | GO:0031175 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDH23 PCDH12 FAT1 NECTIN2 FAT4 NRCAM PCDHGA4 FAT3 ROBO2 CDH2 CDH3 CDH4 | 9.33e-06 | 187 | 278 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 2.37e-05 | 5 | 278 | 3 | GO:0048496 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NRG1 MAPT MYO10 LYPLA2 LRRK2 CDH23 EPB41L3 DIP2A FAT1 NEO1 YAP1 KDR DMD DMRT1 CACNA1A KIF13B HSPG2 FN1 NRCAM FAT3 APBB2 FRYL SHANK3 GRIP1 ARHGEF40 SH3D19 PAFAH1B1 LRP6 MACF1 ROBO2 BRSK1 CDH2 CDH3 CDH4 | 3.14e-05 | 1194 | 278 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | NRG1 TOX MAPT MYO10 LRRK2 NEO1 SERPINI1 NFE2L2 YAP1 DMD CACNA1A KIF13B FN1 NRCAM FAT3 DDR2 SHANK3 SCARF1 GRIP1 PAFAH1B1 LRP6 MACF1 ROBO2 BRSK1 CDH2 CDH4 HTT | 3.23e-05 | 846 | 278 | 27 | GO:0120035 |
| GeneOntologyBiologicalProcess | response to muscle stretch | 3.27e-05 | 28 | 278 | 5 | GO:0035994 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | NRG1 TOX MAPT MYO10 LRRK2 NEO1 SERPINI1 NFE2L2 YAP1 DMD CACNA1A KIF13B FN1 NRCAM FAT3 DDR2 SHANK3 SCARF1 GRIP1 PAFAH1B1 LRP6 MACF1 ROBO2 BRSK1 CDH2 CDH4 HTT | 4.55e-05 | 863 | 278 | 27 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of grooming behavior | 4.70e-05 | 6 | 278 | 3 | GO:2000821 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 7.71e-05 | 132 | 278 | 9 | GO:0000956 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | TOX LRRK2 SALL1 TACC3 TACC2 ELL3 SHANK3 PAFAH1B1 CNTNAP4 LRP6 RORA CDH2 | 8.12e-05 | 233 | 278 | 12 | GO:0061351 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | NRG1 CDH23 PCDH12 FAT1 NECTIN2 FAT4 NRCAM PCDHGA4 FAT3 SCARF1 ROBO2 CDH2 CDH3 CDH4 | 9.63e-05 | 313 | 278 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | locomotory behavior | NRG1 PDE1B MAPT LRRK2 CDH23 ATXN1 DMD CACNA1A CACNA1B HIPK2 SHANK3 PAFAH1B1 HTT | 1.36e-04 | 284 | 278 | 13 | GO:0007626 |
| GeneOntologyBiologicalProcess | mRNA transport | 1.58e-04 | 145 | 278 | 9 | GO:0051028 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular transport | 1.69e-04 | 61 | 278 | 6 | GO:0032387 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway involved in heart development | 1.81e-04 | 2 | 278 | 2 | GO:0003307 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway involved in heart development | 1.81e-04 | 2 | 278 | 2 | GO:0003308 | |
| GeneOntologyBiologicalProcess | cellular response to angiotensin | 1.92e-04 | 40 | 278 | 5 | GO:1904385 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 1.95e-04 | 22 | 278 | 4 | GO:0097091 | |
| MousePheno | abnormal neurite morphology | MAPT LRRK2 L2HGDH EPB41L3 ATXN1 MLC1 NFE2L2 HERC2 CACNA1A HSPG2 ANK2 NRCAM ECPAS NR1D1 SHANK3 KANSL1 SBF2 ROBO2 RORA MBD5 HTT | 2.56e-06 | 442 | 207 | 21 | MP:0008415 |
| MousePheno | abnormal synapse morphology | NRG1 MAPT YAP1 DMD BSN DYNC1H1 CACNA1A HSPG2 ANK2 PCLO SHANK3 SLC18A3 CNTNAP4 CDH2 | 6.21e-06 | 224 | 207 | 14 | MP:0009538 |
| MousePheno | abnormal axon morphology | MAPT LRRK2 L2HGDH EPB41L3 MLC1 NFE2L2 CACNA1A HSPG2 ANK2 NRCAM ECPAS SBF2 HTT | 8.33e-06 | 199 | 207 | 13 | MP:0005404 |
| MousePheno | delayed brain development | 1.42e-05 | 11 | 207 | 4 | MP:0001889 | |
| MousePheno | abnormal radial glial cell morphology | 2.29e-05 | 24 | 207 | 5 | MP:0003648 | |
| MousePheno | abnormal taurine level | 3.01e-05 | 13 | 207 | 4 | MP:0030634 | |
| MousePheno | abnormal reflex | NRG1 TOX MYO10 CDH23 MPDZ ADGRV1 GMEB2 EPB41L3 RYR1 RYR2 ARID1B KCNA2 GSPT2 ATXN1 TECPR2 RELL1 BSN GNL1 DYNC1H1 CACNA1A CACNA1B RELCH NRCAM HIPK2 AIRE MSL1 BTBD2 NR1D1 SHANK3 VWA5A SBF2 PAFAH1B1 CNTNAP4 TSPYL5 RORA SPAG17 CDH2 HTT | 3.10e-05 | 1294 | 207 | 38 | MP:0001961 |
| MousePheno | increased taurine level | 3.13e-05 | 5 | 207 | 3 | MP:0030635 | |
| MousePheno | abnormal synaptic transmission | NRG1 TOX MAPT DBNDD2 LRRK2 ADGRV1 RYR2 ARID1B KCNA2 FBXO9 ATXN1 CASKIN2 RELL1 BSN HJV CACNA1A CACNA1B HSPG2 ANK2 NRCAM PCLO ARHGEF12 AIRE ECPAS SHANK3 SLC18A3 LPIN2 CNTNAP4 GPCPD1 RORA CDH2 NEURL4 ALPK2 | 4.33e-05 | 1070 | 207 | 33 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | NRG1 TOX MAPT DBNDD2 LRRK2 ADGRV1 RYR2 ARID1B KCNA2 FBXO9 ATXN1 CASKIN2 RELL1 BSN HJV CACNA1A CACNA1B HSPG2 ANK2 NRCAM PCLO ARHGEF12 AIRE ECPAS SHANK3 SLC18A3 LPIN2 CNTNAP4 GPCPD1 RORA CDH2 NEURL4 ALPK2 | 4.84e-05 | 1076 | 207 | 33 | MP:0021009 |
| MousePheno | abnormal CNS synaptic transmission | NRG1 TOX MAPT DBNDD2 LRRK2 ADGRV1 RYR2 ARID1B KCNA2 FBXO9 ATXN1 CASKIN2 RELL1 BSN HJV CACNA1A CACNA1B ANK2 NRCAM PCLO ARHGEF12 AIRE ECPAS SHANK3 LPIN2 CNTNAP4 GPCPD1 RORA CDH2 NEURL4 ALPK2 | 5.22e-05 | 985 | 207 | 31 | MP:0002206 |
| MousePheno | abnormal behavioral response to xenobiotic | MAPT LRRK2 MPDZ L2HGDH RYR1 RYR2 KCNA2 PER2 BSN CACNA1A CACNA1B HIPK2 ECPAS SHANK3 SLC18A3 | 5.75e-05 | 309 | 207 | 15 | MP:0009745 |
| MousePheno | limb grasping | EPB41L3 KCNA2 ATXN1 GNL1 DYNC1H1 CACNA1A NRCAM HIPK2 AIRE BTBD2 SBF2 PAFAH1B1 RORA SPAG17 HTT | 1.01e-04 | 325 | 207 | 15 | MP:0001513 |
| MousePheno | increased grooming behavior | 1.10e-04 | 74 | 207 | 7 | MP:0001441 | |
| MousePheno | abnormal nervous system electrophysiology | NRG1 LRRK2 CDH23 EPB41L3 RYR2 KCNA2 PER2 BSN CACNA1A CACNA1B HSPG2 NRCAM SHANK3 GSN SBF2 | 1.16e-04 | 329 | 207 | 15 | MP:0002272 |
| MousePheno | decreased grip strength | MAPT GBE1 MPDZ RYR1 ARID1B KCNA2 SH3TC1 C5 TAF2 DMD DYNC1H1 CACNA1A CACNA1B NRCAM CCDC92 SHANK3 SLC18A3 SH3D19 RORA MBD5 HTT | 1.27e-04 | 575 | 207 | 21 | MP:0010053 |
| MousePheno | abnormal grooming behavior | 2.01e-04 | 137 | 207 | 9 | MP:0001440 | |
| MousePheno | abnormal Purkinje cell dendrite morphology | 2.09e-04 | 58 | 207 | 6 | MP:0008572 | |
| MousePheno | abnormal stride length | 2.10e-04 | 82 | 207 | 7 | MP:0012690 | |
| MousePheno | increased susceptibility to malignant hyperthermia | 2.18e-04 | 2 | 207 | 2 | MP:0020214 | |
| MousePheno | neuronal intranuclear inclusions | 2.52e-04 | 9 | 207 | 3 | MP:0004191 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | NRG1 TOX MYO10 CDH23 MPDZ ADGRV1 GMEB2 EPB41L3 PTGIR RYR1 RYR2 ARID1B KCNA2 GSPT2 ATXN1 TECPR2 RELL1 BSN GNL1 DYNC1H1 CACNA1A CACNA1B RELCH NRCAM HIPK2 AIRE MSL1 BTBD2 NR1D1 SHANK3 VWA5A SBF2 PAFAH1B1 CNTNAP4 TSPYL5 RORA SPAG17 CDH2 HTT | 2.68e-04 | 1486 | 207 | 39 | MP:0002067 |
| MousePheno | impaired coordination | MAPT ARID1B KCNA2 ATXN1 HERC2 DMD DYNC1H1 CACNA1A NRCAM HIPK2 SHANK3 SLC18A3 SBF2 PAFAH1B1 CNTNAP4 RORA MBD5 HTT | 2.71e-04 | 478 | 207 | 18 | MP:0001405 |
| Domain | Znf_CCHC | 1.69e-05 | 55 | 279 | 7 | IPR001878 | |
| Domain | ZnF_C2HC | 1.69e-05 | 55 | 279 | 7 | SM00343 | |
| Domain | LAM_G_DOMAIN | 1.95e-05 | 38 | 279 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 2.64e-05 | 40 | 279 | 6 | PF02210 | |
| Domain | ConA-like_dom | ADGRV1 TRIM22 RYR1 RYR2 FAT1 USH2A HSPG2 FAT4 FAT3 LGALSL CNTNAP4 NEURL4 RFPL2 | 2.69e-05 | 219 | 279 | 13 | IPR013320 |
| Domain | Cadherin_CS | 3.77e-05 | 109 | 279 | 9 | IPR020894 | |
| Domain | LamG | 4.61e-05 | 44 | 279 | 6 | SM00282 | |
| Domain | CADHERIN_1 | 5.01e-05 | 113 | 279 | 9 | PS00232 | |
| Domain | Cadherin | 5.01e-05 | 113 | 279 | 9 | PF00028 | |
| Domain | - | 5.37e-05 | 114 | 279 | 9 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 5.37e-05 | 114 | 279 | 9 | PS50268 | |
| Domain | CA | 5.75e-05 | 115 | 279 | 9 | SM00112 | |
| Domain | Cadherin-like | 6.16e-05 | 116 | 279 | 9 | IPR015919 | |
| Domain | Cadherin | 7.03e-05 | 118 | 279 | 9 | IPR002126 | |
| Domain | - | 8.87e-05 | 95 | 279 | 8 | 2.60.120.200 | |
| Domain | Cadherin_pro | 1.75e-04 | 8 | 279 | 3 | SM01055 | |
| Domain | VIT | 1.75e-04 | 8 | 279 | 3 | PF08487 | |
| Domain | Cadherin_pro_dom | 1.75e-04 | 8 | 279 | 3 | IPR014868 | |
| Domain | VIT | 1.75e-04 | 8 | 279 | 3 | SM00609 | |
| Domain | Laminin_G | 2.22e-04 | 58 | 279 | 6 | IPR001791 | |
| Domain | Znf_piccolo | 2.22e-04 | 2 | 279 | 2 | IPR008899 | |
| Domain | zf-piccolo | 2.22e-04 | 2 | 279 | 2 | PF05715 | |
| Domain | VIT | 3.66e-04 | 10 | 279 | 3 | PS51468 | |
| Domain | VIT | 3.66e-04 | 10 | 279 | 3 | IPR013694 | |
| Domain | EGF_1 | NRG1 ADAM19 FAT1 USH2A VWA2 HSPG2 FAT4 FN1 FAT3 SCARF1 CNTNAP4 LRP6 | 4.76e-04 | 255 | 279 | 12 | PS00022 |
| Domain | TACC | 6.60e-04 | 3 | 279 | 2 | PF05010 | |
| Domain | PEHE | 6.60e-04 | 3 | 279 | 2 | PF15275 | |
| Domain | PEHE | 6.60e-04 | 3 | 279 | 2 | SM01300 | |
| Domain | PEHE_dom | 6.60e-04 | 3 | 279 | 2 | IPR029332 | |
| Domain | RyR | 6.60e-04 | 3 | 279 | 2 | PF02026 | |
| Domain | Beta-propeller_rpt_TECPR | 6.60e-04 | 3 | 279 | 2 | IPR006624 | |
| Domain | RR_TM4-6 | 6.60e-04 | 3 | 279 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.60e-04 | 3 | 279 | 2 | IPR013333 | |
| Domain | TECPR | 6.60e-04 | 3 | 279 | 2 | SM00706 | |
| Domain | Ryanodine_rcpt | 6.60e-04 | 3 | 279 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 6.60e-04 | 3 | 279 | 2 | IPR009460 | |
| Domain | TACC | 6.60e-04 | 3 | 279 | 2 | IPR007707 | |
| Domain | ARM-like | SMG1 LRRK2 ARID1B RRP12 RELCH RANBP6 FRYL ECPAS IQCB1 STKLD1 HTT PPP6R3 | 7.88e-04 | 270 | 279 | 12 | IPR011989 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.15e-05 | 11 | 198 | 4 | M47958 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 7.69e-05 | 32 | 198 | 5 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 8.96e-05 | 33 | 198 | 5 | M27016 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.43e-05 | 53 | 198 | 6 | M27212 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 1.04e-04 | 34 | 198 | 5 | M27041 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.05e-04 | 54 | 198 | 6 | M29594 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.16e-04 | 55 | 198 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.20e-04 | 35 | 198 | 5 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.38e-04 | 36 | 198 | 5 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.38e-04 | 36 | 198 | 5 | M27245 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.57e-04 | 58 | 198 | 6 | MM14736 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.57e-04 | 37 | 198 | 5 | M27038 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.57e-04 | 37 | 198 | 5 | M1029 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.03e-04 | 39 | 198 | 5 | M27238 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.29e-04 | 40 | 198 | 5 | MM15060 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.29e-04 | 40 | 198 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.58e-04 | 41 | 198 | 5 | MM15200 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 2.58e-04 | 41 | 198 | 5 | M29574 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.81e-04 | 151 | 198 | 9 | M550 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.90e-04 | 42 | 198 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.24e-04 | 43 | 198 | 5 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.24e-04 | 43 | 198 | 5 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 3.62e-04 | 44 | 198 | 5 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 4.46e-04 | 46 | 198 | 5 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.94e-04 | 47 | 198 | 5 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.94e-04 | 47 | 198 | 5 | MM14939 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 5.45e-04 | 48 | 198 | 5 | MM15069 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 5.97e-04 | 74 | 198 | 6 | M48006 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.00e-04 | 49 | 198 | 5 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION | 6.41e-04 | 169 | 198 | 9 | MM14919 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.59e-04 | 50 | 198 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.23e-04 | 51 | 198 | 5 | MM15151 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.37e-04 | 77 | 198 | 6 | M27226 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 7.77e-04 | 30 | 198 | 4 | M47752 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 8.64e-04 | 109 | 198 | 7 | M39542 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 PPRC1 MYO10 TMC6 ANKHD1 BIRC6 RYR1 ACOX3 ZCCHC14 DIP2A FAT1 PER2 SH3TC1 NFKB2 RRP12 HERC2 DYNC1H1 WNK2 HSPG2 HECTD4 FRYL NUP214 FAAP100 SH2B2 NHSL1 INTS5 ARHGEF40 KANSL1 SBF2 AKAP13 DEPDC5 MBD5 DHX34 HCFC1 HTT AHNAK2 | 2.72e-12 | 1105 | 287 | 36 | 35748872 |
| Pubmed | FAM90A17 FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.87e-11 | 25 | 287 | 8 | 17684299 | |
| Pubmed | SMG1 NCOA6 AKAP8 RBM10 GMEB2 ANKHD1 RNF214 FAT1 ARID1B SALL1 ATXN1 YAP1 NFKB2 RRP12 TAF2 HERC2 CNOT3 DYNC1H1 HSPG2 ZBTB33 CNOT10 RBMS1 HIPK2 GCM1 SLU7 CCT4 MSL1 NUP214 RFX1 MED15 ZZZ3 KANSL1 LRP6 YY1AP1 HCFC1 DCP1A PPP6R3 HELLS | 2.40e-10 | 1429 | 287 | 38 | 35140242 | |
| Pubmed | PPRC1 MYO10 RBM10 SLC25A25 ZCCHC14 PXDN PER2 MLC1 RRP12 DYNC1H1 FKBP15 NRCAM ARHGEF12 NUP214 VAT1L KANSL1 GPCPD1 MACF1 YY1AP1 SON | 2.53e-10 | 407 | 287 | 20 | 12693553 | |
| Pubmed | 5.30e-10 | 23 | 287 | 7 | 18602769 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR NCOA6 AKAP8 MAPT RBM10 MCM3 DHX9 YAP1 RRP12 TACC3 CNOT3 ELOA NUP214 RUNX1 ECPAS NR1D1 RFX1 TUBGCP6 INTS5 KANSL1 TRAPPC10 YY1AP1 DDX20 DCP1A PPP6R3 SON | 1.87e-09 | 774 | 287 | 26 | 15302935 |
| Pubmed | PDXDC1 AKAP8 LRRK2 MCM3 EPB41L3 BIRC6 RYR2 DHX9 FAT1 NEO1 SYDE2 NECTIN2 RELL1 TACC3 NUP160 DYNC1H1 FAT4 ZBTB33 FN1 APBB2 MUC16 CCT4 PKHD1L1 GTPBP2 USO1 HELLS | 2.03e-09 | 777 | 287 | 26 | 35844135 | |
| Pubmed | TPR CCPG1 RBM10 DHX9 RRP12 NUP210 HERC2 NUP160 ZBTB33 HECTD4 NUP214 NR1D1 NUP133 DHX34 SON | 3.19e-09 | 250 | 287 | 15 | 33536335 | |
| Pubmed | SMG1 NCOA6 SANBR ADGRV1 GMEB2 ANKHD1 ARID1B TECPR2 CASKIN2 BSN WNK2 RELCH HECTD4 ECPAS TUBGCP6 ZFYVE28 INTS5 ROBO2 DEPDC5 DHX34 PPP6R3 | 4.10e-09 | 529 | 287 | 21 | 14621295 | |
| Pubmed | EXPH5 EPB41L3 BIRC6 PARP4 NUP210 KAZN NUP160 CNOT3 KIF13B VARS2 ATP8B2 SHANK3 CEP72 SBF2 SOCS5 CNTNAP4 MACF1 TSPYL5 MBD5 NEURL4 | 6.75e-09 | 493 | 287 | 20 | 15368895 | |
| Pubmed | TPR EPB41L3 ANKHD1 BIRC6 DNTTIP2 RRP12 NUP210 HERC2 NUP160 DYNC1H1 FN1 FRYL NUP214 ECPAS TBL3 NUP133 MACF1 DDX20 ZBTB11 HCFC1 HERC5 PPP6R3 SON | 6.98e-09 | 653 | 287 | 23 | 22586326 | |
| Pubmed | TPR AKAP8 PDE1B MPDZ MCM3 EPB41L3 KCNA2 HERC2 TACC3 BSN DYNC1H1 WNK2 CACNA1A KIF13B FKBP15 ANK2 NRCAM HECTD4 ARHGEF12 CCT4 SHANK3 GSN SH3D19 MACF1 BRSK1 CDH2 TNS1 NEURL4 | 1.01e-08 | 963 | 287 | 28 | 28671696 | |
| Pubmed | SMG1 NCOA6 RYR1 RYR2 PARP4 ARID1B SALL1 NOL7 C5 TAF2 BSN ARMT1 FAT4 SMARCAL1 MUC16 SLU7 RFX1 TBL3 MED15 CEP72 AHNAK2 HELLS | 2.19e-08 | 638 | 287 | 22 | 31182584 | |
| Pubmed | TPR EXPH5 NCKAP5 EPB41L3 ATXN1 HERC2 DMD WNK2 CCDC14 HIPK2 CCDC92 NUP214 KANSL1 SH3D19 MACF1 AKAP13 YY1AP1 MBD5 TNS1 | 2.92e-08 | 486 | 287 | 19 | 20936779 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 AKAP8 RBM10 MCM3 DNTTIP2 DHX9 ARID1B RRP12 NUP210 HERC2 NUP160 HECTD4 EXOSC3 NUP214 TBL3 NUP133 ZBTB11 PPP6R3 | 3.44e-08 | 440 | 287 | 18 | 34244565 |
| Pubmed | TPR NCOA6 RBM10 MPDZ MCM3 ANKHD1 ARID1B YAP1 TAF2 TACC3 DYNC1H1 ZBTB33 RFX1 MED15 ZZZ3 SH3D19 HCFC1 HTT DCP1A PPP6R3 | 4.00e-08 | 549 | 287 | 20 | 38280479 | |
| Pubmed | SMG1 PCDH12 BIRC6 DNTTIP2 RYR1 PARP4 NEO1 ARID1B ATXN1 MYO18B COPS6 ARMT1 HSPG2 FN1 ANK2 AOC3 NUP133 MACF1 SON | 4.15e-08 | 497 | 287 | 19 | 23414517 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR MCM3 EPB41L3 ANKHD1 BIRC6 DNTTIP2 DHX9 NFKB2 RRP12 TAF2 HERC2 NUP160 DYNC1H1 FN1 EXOSC3 SLU7 CCT4 NUP214 RUNX1 TBL3 AARSD1 ARHGEF40 KANSL1 PAFAH1B1 NUP133 MACF1 AKAP13 DDX20 DHX34 DCP1A SON AHNAK2 | 1.06e-07 | 1353 | 287 | 32 | 29467282 |
| Pubmed | SMG1 NCOA6 EXPH5 ACOX3 RYR2 ARID1B HERC2 DYNC1H1 HSPG2 FN1 RANBP6 BTBD2 RFX1 GRIP1 KANSL1 POLI MACF1 ZBTB11 DCP1A SON | 1.31e-07 | 591 | 287 | 20 | 15231748 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | TPR EPB41L3 NEO1 BSN DYNC1H1 WNK2 ANK2 NRCAM PCLO SHANK3 PAFAH1B1 HTT | 1.36e-07 | 202 | 287 | 12 | 33601422 |
| Pubmed | 1.83e-07 | 102 | 287 | 9 | 9734811 | ||
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 5.56e-07 | 3 | 287 | 3 | 24394417 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | AKAP8 RBM10 EML5 UBE2G2 PER2 NFE2L2 NFKB2 DYNC1H1 SBF2 LPIN2 AKAP13 SON | 6.02e-07 | 232 | 287 | 12 | 25515538 |
| Pubmed | CCPG1 RBM10 ANKHD1 TRIM22 NFE2L2 BSN WNK2 CACNA1A SHANK3 SLC18A3 CCDC17 NEURL4 | 6.30e-07 | 233 | 287 | 12 | 37704626 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 CCPG1 SALL1 GSPT2 NFE2L2 YAP1 KDR BSN DYNC1H1 WNK2 NUP214 SYT14 AKAP13 TSHZ1 NEURL4 SON | 7.08e-07 | 430 | 287 | 16 | 35044719 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 7.36e-07 | 120 | 287 | 9 | 31413325 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR AKAP8 ANKHD1 SALL1 SH3TC1 NFATC2 NFKB2 NUP160 DYNC1H1 ZBTB33 SMARCAL1 SLU7 ECPAS RFX1 FAAP100 KANSL1 USO1 NUP133 TSHZ1 HCFC1 HERC5 DCP1A HELLS | 8.87e-07 | 857 | 287 | 23 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 AKAP8 MAPT EXPH5 MPDZ EPB41L3 ZCCHC14 ATXN1 CASKIN2 YAP1 SYDE2 NECTIN2 KIF13B FRYL GRIP1 NHSL1 USO1 SH3D19 IQCB1 MACF1 AKAP13 DCP1A AHNAK2 | 9.60e-07 | 861 | 287 | 23 | 36931259 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | DHX9 PARP4 PXDN RRP12 NUP210 HERC2 FRYL ECPAS ARHGEF40 AKAP13 NEURL4 | 1.08e-06 | 202 | 287 | 11 | 33005030 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR RBM10 LYPLA2 EPB41L3 ANKHD1 DNTTIP2 RRP12 FKBP15 ELOA ZBTB33 ANK2 CCT4 TACC2 NUP214 SH3D19 NUP133 MACF1 HCFC1 HERC5 DCP1A PPP6R3 SON AHNAK2 HELLS | 1.09e-06 | 934 | 287 | 24 | 33916271 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR AKAP8 BPIFB1 DHX9 ARID1B PER2 RRP12 HERC2 TACC3 COPS6 GNL1 NUP160 CNOT3 DYNC1H1 CNOT10 MSL1 TACC2 NUP214 FAAP100 TUBGCP6 KANSL1 CEP72 SH3D19 PAFAH1B1 NUP133 NEURL4 HCFC1 | 1.39e-06 | 1155 | 287 | 27 | 20360068 |
| Pubmed | 1.72e-06 | 25 | 287 | 5 | 10601273 | ||
| Pubmed | RYR1 SPTBN5 NEO1 NFKB2 NUP210 WNK2 HSPG2 FN1 CCT4 SH2B2 HERC5 | 1.89e-06 | 214 | 287 | 11 | 22199357 | |
| Pubmed | 2.11e-06 | 26 | 287 | 5 | 12228227 | ||
| Pubmed | 2.21e-06 | 4 | 287 | 3 | 9441666 | ||
| Pubmed | 2.21e-06 | 4 | 287 | 3 | 9015265 | ||
| Pubmed | MOSPD2 BIRC6 ARID1B CASKIN2 RRP12 NUP210 NECTIN2 RELL1 HERC2 DMD CCDC14 ARMT1 ELOA RELCH CCT4 NHSL1 CEP72 SBF2 NUP133 LRP6 TNS1 NEURL4 DCP1A PPP6R3 HELLS | 2.48e-06 | 1049 | 287 | 25 | 27880917 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MPDZ ITIH3 DHX9 HERC2 GNL1 CACNA1A CACNA1B FN1 ARHGEF12 NUP214 TUBGCP6 KANSL1 KANK4 DDX20 HTT DCP1A | 2.57e-06 | 475 | 287 | 16 | 31040226 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TIGD4 BIRC6 RYR1 DHX9 DIP2A PARP4 SYDE2 KAZN DYNC1H1 FAT4 FN1 HSPBAP1 PCLO EXOSC3 ECPAS ZFYVE28 ZZZ3 LGALSL AKAP13 ZBTB11 | 3.88e-06 | 736 | 287 | 20 | 29676528 |
| Pubmed | 4.26e-06 | 14 | 287 | 4 | 21228161 | ||
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 4.45e-06 | 30 | 287 | 5 | 24315095 | |
| Pubmed | 4.45e-06 | 30 | 287 | 5 | 27016207 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPR SMG1 MAPT EPB41L3 DHX9 RRP12 GNL1 ARMT1 PCLO NUP214 ECPAS AARSD1 GRIP1 MACF1 HCFC1 PPP6R3 | 4.68e-06 | 498 | 287 | 16 | 36634849 |
| Pubmed | 4.97e-06 | 151 | 287 | 9 | 17043677 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | GMEB2 EPB41L3 TRIM22 DNTTIP2 SALL1 ZBTB33 SLU7 TACC2 MED15 ZZZ3 VWA5A HCFC1 DCP1A AHNAK2 HELLS | 5.11e-06 | 444 | 287 | 15 | 34795231 |
| Pubmed | 5.24e-06 | 152 | 287 | 9 | 34299191 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR NCOA6 RBM10 MCM3 EPB41L3 DNTTIP2 DHX9 ARID1B SALL1 NOL7 ELOA ZBTB33 RBMS1 SLU7 MSL1 NUP214 RFX1 TBL3 YBX2 ZZZ3 HCFC1 SON HELLS | 5.27e-06 | 954 | 287 | 23 | 36373674 |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 5.27e-06 | 31 | 287 | 5 | 11431694 | |
| Pubmed | 5.49e-06 | 5 | 287 | 3 | 30862798 | ||
| Pubmed | 5.49e-06 | 5 | 287 | 3 | 23060442 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDH23 MCM3 SUCLG1 DHX9 RNF214 EML5 YAP1 NECTIN2 COPS6 NUP160 DYNC1H1 KIF13B FKBP15 ELOA RELCH CNOT10 RBMS1 RFX1 FAAP100 GSN MED15 PAFAH1B1 IQCB1 NUP133 TRAPPC10 DDX20 NEURL4 DCP1A | 5.67e-06 | 1321 | 287 | 28 | 27173435 |
| Pubmed | PDXDC1 ANKHD1 NFKB2 RRP12 FKBP15 RELCH CNOT10 CCT4 IQCB1 HTT SON HELLS | 5.68e-06 | 288 | 287 | 12 | 23383273 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | TPR AKAP8 DNTTIP2 RRP12 CCT4 RUNX1 YBX2 IQCB1 NUP133 DDX20 PPP6R3 SON | 5.88e-06 | 289 | 287 | 12 | 23752268 |
| Pubmed | TPR MPDZ MCM3 EPB41L3 DHX9 NECTIN2 DYNC1H1 ZBTB33 ANK2 ARHGEF12 CCT4 NUP214 ECPAS GRIP1 USO1 SH3D19 LRP6 MACF1 HCFC1 | 8.10e-06 | 708 | 287 | 19 | 39231216 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A17 NFKB2 FAM90A19 FN1 GCM1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 9.71e-06 | 164 | 287 | 9 | 22967998 |
| Pubmed | DBNDD2 LRRK2 ZCCHC14 RNF214 FAT1 PXDN NECTIN2 HERC2 NUP160 MOCS1 CCDC14 ANK2 RBMS1 FAT3 HIPK2 TACC2 FAAP100 TUBGCP6 GTPBP2 KANK4 ADAMTS14 CDH2 DHX34 CDH3 DCP1A PPP6R3 | 1.05e-05 | 1215 | 287 | 26 | 15146197 | |
| Pubmed | 1.09e-05 | 6 | 287 | 3 | 9226036 | ||
| Pubmed | 1.09e-05 | 6 | 287 | 3 | 31804576 | ||
| Pubmed | Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. | 1.09e-05 | 6 | 287 | 3 | 24842889 | |
| Pubmed | TPR EPB41L3 ANKHD1 BIRC6 SALL1 TACC3 ZBTB33 NUP214 ECPAS RFX1 ZZZ3 USO1 ZBTB11 DCP1A | 1.16e-05 | 418 | 287 | 14 | 34709266 | |
| Pubmed | 1.19e-05 | 128 | 287 | 8 | 23858473 | ||
| Pubmed | 1.25e-05 | 129 | 287 | 8 | 23022380 | ||
| Pubmed | 1.27e-05 | 18 | 287 | 4 | 26209645 | ||
| Pubmed | MOSPD2 AKAP8 MPDZ BIRC6 ZCCHC14 NEO1 ARID1B YAP1 FKBP15 ELOA ZBTB33 NUP214 USO1 IQCB1 AKAP13 DDX20 HCFC1 SLC26A6 DCP1A | 1.31e-05 | 733 | 287 | 19 | 34672954 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.33e-05 | 130 | 287 | 8 | 35545047 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | NFATC2 CNOT3 DYNC1H1 ZBTB33 SLU7 CCT4 MSL1 NUP214 RUNX1 TBL3 GSN MED15 USO1 | 1.45e-05 | 370 | 287 | 13 | 22922362 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.48e-05 | 38 | 287 | 5 | 12791264 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.63e-05 | 220 | 287 | 10 | 35785414 | |
| Pubmed | TPR AKAP8 MCM3 DHX9 PARP4 NUP160 CCT4 NUP214 ECPAS TBL3 USO1 CEP72 NUP133 HCFC1 PPP6R3 | 1.80e-05 | 494 | 287 | 15 | 26831064 | |
| Pubmed | CCPG1 MOSPD2 AKAP8 PBDC1 MPDZ EPB41L3 DNTTIP2 DHX9 DIP2A NEO1 UBE2G2 CASKIN2 RRP12 NUP210 NECTIN2 RELL1 HERC2 ANK2 SLU7 VARS2 TBL3 TUBGCP6 NUP133 MACF1 AKAP13 NEURL4 HERC5 PPP6R3 HELLS | 1.83e-05 | 1487 | 287 | 29 | 33957083 | |
| Pubmed | 1.90e-05 | 7 | 287 | 3 | 20058854 | ||
| Pubmed | 1.90e-05 | 7 | 287 | 3 | 16059920 | ||
| Pubmed | 1.90e-05 | 7 | 287 | 3 | 9226037 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 1.90e-05 | 7 | 287 | 3 | 11839813 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.90e-05 | 7 | 287 | 3 | 22510986 | |
| Pubmed | The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1). | 1.90e-05 | 7 | 287 | 3 | 10860780 | |
| Pubmed | 1.90e-05 | 7 | 287 | 3 | 17098863 | ||
| Pubmed | 1.92e-05 | 40 | 287 | 5 | 37516964 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SERPINI1 ATXN1 KAZN TACC3 COPS6 FN1 FRYL TACC2 CCDC92 BTBD2 NR1D1 SHANK3 GRIP1 CEP72 NUP133 YY1AP1 | 1.99e-05 | 560 | 287 | 16 | 21653829 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | AKAP8 BIRC6 DNTTIP2 DHX9 RRP12 NOL7 HERC2 ELOA EXOSC3 SLU7 TACC2 TBL3 IQCB1 NUP133 MACF1 ZBTB11 NEURL4 HERC5 SON | 2.12e-05 | 759 | 287 | 19 | 35915203 |
| Pubmed | AKAP8 MAPT BPIFB1 EPB41L3 SUCLG1 ANKHD1 DNTTIP2 FAT1 ARID1B EML5 SH3TC1 ATXN1 TAF2 ZBTB33 FAT3 ELL3 TUBGCP6 GTPBP2 ARHGEF40 MLH3 ZZZ3 MACF1 DHX34 SON | 2.15e-05 | 1116 | 287 | 24 | 31753913 | |
| Pubmed | SMG1 CPAMD8 CCPG1 RBM10 TMC6 PTGIR DNTTIP2 MLC1 AK5 C5 HJV CACNA1B TBL3 ZZZ3 ZSCAN22 PCSK7 YY1AP1 DHX34 HERC5 AHNAK2 | 2.29e-05 | 832 | 287 | 20 | 36724073 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.33e-05 | 183 | 287 | 9 | 31932471 | |
| Pubmed | MPDZ EPB41L3 BIRC6 ARID1B YAP1 NUP160 FKBP15 CNOT10 FRYL ECPAS GRIP1 CEP72 TRAPPC10 PPP6R3 | 2.38e-05 | 446 | 287 | 14 | 24255178 | |
| Pubmed | 2.44e-05 | 103 | 287 | 7 | 10574462 | ||
| Pubmed | 2.60e-05 | 104 | 287 | 7 | 9205841 | ||
| Pubmed | 2.75e-05 | 43 | 287 | 5 | 36950384 | ||
| Pubmed | The imprinted Phlda2 gene regulates extraembryonic energy stores. | 2.95e-05 | 22 | 287 | 4 | 19884348 | |
| Pubmed | TPR MAPT SANBR EPB41L3 SUCLG1 BIRC6 RYR2 NEO1 GSPT2 BSN CNOT3 WNK2 CACNA1A CACNA1B FKBP15 RELCH ANK2 NRCAM PCLO CCT4 TACC2 SHANK3 NHSL1 MACF1 | 2.98e-05 | 1139 | 287 | 24 | 36417873 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 3.02e-05 | 8 | 287 | 3 | 19683999 | |
| Pubmed | 3.02e-05 | 8 | 287 | 3 | 24509916 | ||
| Pubmed | Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. | 3.02e-05 | 8 | 287 | 3 | 22170608 | |
| Pubmed | Essential roles of Meltrin beta (ADAM19) in heart development. | 3.02e-05 | 8 | 287 | 3 | 14975714 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 RBM10 ARID1B YAP1 NUP210 KIF13B SMARCAL1 ECPAS RFX1 YY1AP1 HCFC1 DCP1A | 3.04e-05 | 341 | 287 | 12 | 32971831 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR NRG1 AKAP8 RBM10 TRUB1 EPB41L3 DHX9 PARP4 COPS6 DYNC1H1 CCT4 RNF17 KANSL1 USO1 MACF1 HELLS | 3.17e-05 | 582 | 287 | 16 | 20467437 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.39e-05 | 148 | 287 | 8 | 32538781 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MCM3 SALL1 YAP1 NFKB2 BSN CNOT3 KIF13B HIPK2 TACC2 ZZZ3 USO1 IQCB1 MACF1 YY1AP1 DDX20 PPP6R3 | 3.58e-05 | 588 | 287 | 16 | 38580884 |
| Pubmed | MAPT EPB41L3 KCNA2 BSN CACNA1A CACNA1B ANK2 NRCAM PCLO CCDC92 MACF1 HTT | 3.60e-05 | 347 | 287 | 12 | 17114649 | |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 4.24e-05 | 24 | 287 | 4 | 26116661 | |
| Pubmed | MOSPD2 AKAP8 MCM3 BIRC6 ACOX3 DHX9 PARP4 NUP210 HERC2 DYNC1H1 FKBP15 CNOT10 SLU7 ECPAS MED15 TUBGCP6 INTS5 USO1 NUP133 AKAP13 DDX20 DHX34 HCFC1 DCP1A | 4.42e-05 | 1168 | 287 | 24 | 19946888 | |
| Interaction | YWHAZ interactions | NRG1 AKAP8 PDE1B MAPT EXPH5 LRRK2 EPB41L3 KRT24 PER2 NFATC2 ATXN1 YAP1 SYDE2 AK5 NECTIN2 HERC2 LNX1 VWA2 DYNC1H1 WNK2 KIF13B ELOA ZBTB33 FN1 HECTD4 FRYL TACC2 SHANK3 GSN GRIP1 NHSL1 SH3D19 PAFAH1B1 LPIN2 MACF1 AKAP13 DEPDC5 TNS1 HTT DCP1A | 1.16e-06 | 1319 | 271 | 40 | int:YWHAZ |
| Interaction | C2CD4B interactions | 1.84e-06 | 44 | 271 | 7 | int:C2CD4B | |
| Interaction | RANBP1 interactions | MAPT INSIG1 LRRK2 MCM3 ATXN1 NUP210 NUP160 FN1 NUP214 IQCB1 NUP133 HERC5 HTT | 5.99e-06 | 211 | 271 | 13 | int:RANBP1 |
| Interaction | YWHAG interactions | NCOA6 AKAP8 MAPT EXPH5 LRRK2 MPDZ MCM3 EPB41L3 DNTTIP2 NFATC2 ATXN1 CASKIN2 YAP1 SYDE2 NECTIN2 KDR LNX1 DYNC1H1 KIF13B ZBTB33 FN1 HECTD4 FRYL SHANK3 GRIP1 NHSL1 SH3D19 PAFAH1B1 TRAPPC10 MACF1 AKAP13 HTT DCP1A PPP6R3 SON AHNAK2 | 1.27e-05 | 1248 | 271 | 36 | int:YWHAG |
| Interaction | SLFN11 interactions | TPR CCPG1 RBM10 DHX9 RRP12 NUP210 HERC2 NUP160 ZBTB33 HECTD4 CCT4 NUP214 NR1D1 H1-6 NUP133 DHX34 SON | 1.46e-05 | 376 | 271 | 17 | int:SLFN11 |
| Interaction | TOP3B interactions | NCOA6 PPRC1 MYO10 TMC6 ANKHD1 BIRC6 RYR1 ACOX3 DHX9 ZCCHC14 DIP2A FAT1 PER2 SH3TC1 NFKB2 RRP12 HERC2 DYNC1H1 WNK2 HSPG2 CNOT10 RBMS1 HECTD4 FRYL NUP214 FAAP100 SH2B2 NHSL1 INTS5 ARHGEF40 KANSL1 SBF2 AKAP13 DEPDC5 DDX20 MBD5 DHX34 HCFC1 HTT AHNAK2 | 1.56e-05 | 1470 | 271 | 40 | int:TOP3B |
| Interaction | YWHAB interactions | AKAP8 MAPT EXPH5 LRRK2 EPB41L3 DHX9 NFATC2 ATXN1 YAP1 SYDE2 NECTIN2 LNX1 VWA2 DYNC1H1 KIF13B FN1 HECTD4 FRYL SHANK3 GRIP1 NHSL1 SH3D19 PAFAH1B1 IQCB1 TRAPPC10 MACF1 AKAP13 HTT DCP1A SON AHNAK2 | 1.78e-05 | 1014 | 271 | 31 | int:YWHAB |
| Interaction | ERC2 interactions | 1.95e-05 | 42 | 271 | 6 | int:ERC2 | |
| Interaction | TUBB4B interactions | TPR AKAP8 MAPT INSIG1 ANKHD1 YAP1 HERC2 TACC3 COPS6 GNL1 DYNC1H1 FN1 AIRE CCT4 TACC2 NUP214 ECPAS PAFAH1B1 IQCB1 NEURL4 PPP6R3 | 2.48e-05 | 560 | 271 | 21 | int:TUBB4B |
| Interaction | CASP3 interactions | AKAP8 MAPT TRUB1 BIRC6 NEO1 NFE2L2 COPS6 ARMT1 GSN USO1 SOCS5 HTT | 3.81e-05 | 216 | 271 | 12 | int:CASP3 |
| Interaction | RPS14P3 interactions | 3.88e-05 | 15 | 271 | 4 | int:RPS14P3 | |
| Interaction | PRSS37 interactions | 3.88e-05 | 15 | 271 | 4 | int:PRSS37 | |
| Interaction | SIRT6 interactions | SMG1 AKAP8 RBM10 MCM3 DNTTIP2 DHX9 FAT1 ARID1B RRP12 NUP210 HERC2 NUP160 FAT4 FAT3 HECTD4 EXOSC3 NUP214 TBL3 IQCB1 NUP133 ZBTB11 PPP6R3 | 4.43e-05 | 628 | 271 | 22 | int:SIRT6 |
| Interaction | HDAC11 interactions | 4.60e-05 | 154 | 271 | 10 | int:HDAC11 | |
| Interaction | RPS6KL1 interactions | 6.06e-05 | 51 | 271 | 6 | int:RPS6KL1 | |
| Interaction | CREBBP interactions | NCOA6 ZBTB17 MAPT GMEB2 ARID1B NFATC2 ATXN1 NFE2L2 YAP1 CNOT3 HIPK2 AIRE GCM1 TACC2 VAT1L RUNX1 GRIP1 RORA CDH2 HERC5 HTT | 6.56e-05 | 599 | 271 | 21 | int:CREBBP |
| Interaction | FBXW11 interactions | AKAP8 MYO10 RBM10 DHX9 EML5 UBE2G2 PER2 NFE2L2 YAP1 NFKB2 KDR DYNC1H1 TUBGCP6 SBF2 LPIN2 AKAP13 HCFC1 SON | 7.89e-05 | 473 | 271 | 18 | int:FBXW11 |
| Interaction | GNA12 interactions | 1.03e-04 | 56 | 271 | 6 | int:GNA12 | |
| Interaction | ITGB3 interactions | 1.05e-04 | 170 | 271 | 10 | int:ITGB3 | |
| Interaction | LRRC31 interactions | DHX9 PARP4 PXDN RRP12 NUP210 HERC2 FRYL ECPAS ARHGEF40 AKAP13 NEURL4 | 1.09e-04 | 205 | 271 | 11 | int:LRRC31 |
| Interaction | YWHAQ interactions | TPR NCOA6 ZBTB17 MAPT EXPH5 LRRK2 MCM3 EPB41L3 DHX9 NFATC2 ATXN1 YAP1 SYDE2 NECTIN2 LNX1 VWA2 DYNC1H1 KIF13B FN1 HECTD4 FRYL SHANK3 GRIP1 NHSL1 USO1 SH3D19 H1-6 MACF1 AKAP13 HTT DCP1A | 1.10e-04 | 1118 | 271 | 31 | int:YWHAQ |
| Interaction | BAG2 interactions | NCOA6 MAPT MYO10 EXPH5 LRRK2 ANKHD1 RNF214 ATXN1 YAP1 TAF2 TACC3 CNOT3 KIF13B FKBP15 FN1 SLU7 RFX1 TBL3 TUBGCP6 IQCB1 HTT | 1.11e-04 | 622 | 271 | 21 | int:BAG2 |
| Interaction | HOMER1 interactions | 1.19e-04 | 140 | 271 | 9 | int:HOMER1 | |
| Interaction | NANOS1 interactions | 1.31e-04 | 20 | 271 | 4 | int:NANOS1 | |
| Interaction | NR3C1 interactions | SMG1 NCOA6 RYR1 RYR2 PARP4 ARID1B SALL1 NFKB2 NUP210 NOL7 C5 TAF2 BSN COPS6 ARMT1 FAT4 SMARCAL1 MUC16 SLU7 NUP214 RFX1 TBL3 MED15 GRIP1 CEP72 RFPL2 AHNAK2 HELLS | 1.33e-04 | 974 | 271 | 28 | int:NR3C1 |
| Interaction | FXR1 interactions | SMG1 MED18 AKAP8 MAPT EPB41L3 ANKHD1 RNF214 ATXN1 YAP1 KAZN HERC2 LNX1 ELOA RBMS1 TACC2 CCDC92 BTBD2 SHANK3 GRIP1 CEP72 YY1AP1 CDH2 | 1.38e-04 | 679 | 271 | 22 | int:FXR1 |
| Cytoband | 8p23.1 | FAM90A17 FAM90A19 PRSS55 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.17e-07 | 154 | 287 | 9 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A17 FAM90A19 PRSS55 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.87e-05 | 234 | 287 | 9 | chr8p23 |
| Cytoband | 3p12.3 | 1.84e-04 | 18 | 287 | 3 | 3p12.3 | |
| Cytoband | 3q21.1 | 2.55e-04 | 20 | 287 | 3 | 3q21.1 | |
| GeneFamily | CD molecules|Type I classical cadherins | 8.79e-06 | 5 | 175 | 3 | 1185 | |
| GeneFamily | Nucleoporins | 1.31e-05 | 32 | 175 | 5 | 1051 | |
| GeneFamily | Cadherin related | 1.83e-05 | 17 | 175 | 4 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.75e-05 | 161 | 175 | 9 | 593 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.78e-04 | 3 | 175 | 2 | 287 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 5.52e-04 | 4 | 175 | 2 | 1244 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.54e-04 | 18 | 175 | 3 | 91 | |
| GeneFamily | PDZ domain containing | 7.04e-04 | 152 | 175 | 7 | 1220 | |
| GeneFamily | Variable charge X/Y family | 1.36e-03 | 6 | 175 | 2 | 368 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.49e-03 | 51 | 175 | 4 | 870 | |
| GeneFamily | Ankyrin repeat domain containing | 2.51e-03 | 242 | 175 | 8 | 403 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.21e-03 | 9 | 175 | 2 | 1234 | |
| GeneFamily | Fibronectin type III domain containing | 4.69e-03 | 160 | 175 | 6 | 555 | |
| GeneFamily | CCR4-NOT transcription complex | 4.84e-03 | 11 | 175 | 2 | 1023 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | TOX GBE1 EPB41L3 ATXN1 NFE2L2 YAP1 KAZN APBB2 GRIP1 SBF2 RORA | 2.23e-06 | 171 | 277 | 11 | M39234 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | NRG1 ADAM19 MCM3 DNTTIP2 ACOX3 DHX9 PARP4 FAT1 PXDN UBE2G2 ATXN1 NFE2L2 HERC2 MYO18B NUP160 TEX261 HSPG2 ANK2 RBMS1 APBB2 RUNX1 ZXDB SBF2 KANK4 ADAMTS14 CDH4 HELLS | 1.03e-05 | 1009 | 277 | 27 | M157 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | TOX MYO10 INSIG1 SLC25A25 ARID1B ATXN1 NFE2L2 KIF13B ARHGEF12 GRIP1 RORA MBD5 | 1.04e-05 | 240 | 277 | 12 | M39236 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CCPG1 MOSPD2 MAPT DBNDD2 ANKHD1 NEO1 SERPINI1 PXDN NFKB2 KAZN FKBP15 NRCAM RBMS1 HECTD4 HIPK2 RANBP6 CCT4 ECPAS NHSL1 KANSL1 VWA5A SH3D19 PAFAH1B1 RORA BRSK1 TNS1 HTT HELLS | 1.80e-05 | 1102 | 277 | 28 | M2369 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | NRG1 ADAM19 MCM3 DNTTIP2 ACOX3 FAT1 PXDN UBE2G2 MYO18B NUP160 TEX261 HSPG2 RBMS1 APBB2 KANK4 ADAMTS14 | 2.12e-05 | 441 | 277 | 16 | M172 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CCPG1 MOSPD2 MAPT DBNDD2 ANKHD1 NEO1 SERPINI1 PXDN NFKB2 KAZN FKBP15 NRCAM RBMS1 HECTD4 HIPK2 RANBP6 CCT4 ECPAS NHSL1 KANSL1 VWA5A SH3D19 PAFAH1B1 RORA BRSK1 TNS1 HTT HELLS | 2.57e-05 | 1124 | 277 | 28 | MM1070 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRG1 MYO10 GBE1 FAT1 ATXN1 YAP1 KAZN DMD NUP160 RBMS1 DDR2 APBB2 FRYL RUNX1 ZZZ3 SOCS5 PAFAH1B1 NUP133 MACF1 AKAP13 ZBTB11 CDH2 SON | 4.49e-05 | 856 | 277 | 23 | M4500 |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | NCOA6 TOX PDE1B SH3TC1 NFATC2 ATXN1 CCDC92 RUNX1 ECPAS AKAP13 | 5.24e-05 | 198 | 277 | 10 | M6511 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | SMG1 DBNDD2 PARP4 WNT9A MSL1 ELL3 ATP10D ZFYVE28 LRP6 CCDC17 | 5.47e-05 | 199 | 277 | 10 | M7414 |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | EXPH5 FBXO9 NFE2L2 ODAM CNOT3 ERICH3 ZBTB33 CAPNS2 TACC2 PKHD1L1 | 5.71e-05 | 200 | 277 | 10 | M5675 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_1_DN | 5.92e-05 | 64 | 277 | 6 | M2237 | |
| Coexpression | TERAMOTO_OPN_TARGETS_CLUSTER_8 | 6.29e-05 | 8 | 277 | 3 | MM525 | |
| Coexpression | TERAMOTO_OPN_TARGETS_CLUSTER_8 | 6.29e-05 | 8 | 277 | 3 | M1204 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | PDXDC1 TOX MYO10 MC4R NCKAP5 ADGRV1 DIP2A FAT1 GSPT2 FBXO9 EML5 ATXN1 NUP210 DMD WNK2 CACNA1A ANK2 NRCAM FAT3 PCLO MAGEH1 HECTD4 YBX2 IQCB1 LPIN2 CDH2 CDH4 | 9.82e-07 | 732 | 273 | 27 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | AKAP8 MYO10 SANBR NCKAP5 DIP2A GSPT2 EML5 NUP210 DMD CACNA1A FAT3 PCLO HIPK2 CDH2 CDH4 | 7.99e-06 | 298 | 273 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TPR SMG1 MYO10 SLC38A5 EPB41L3 BIRC6 RYR2 ZCCHC14 HERC2 RELCH FAT3 HIPK2 NUP214 ECPAS KANSL1 DCP1A SON | 1.12e-05 | 385 | 273 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | AKAP8 TOX MYO10 INSIG1 SANBR NCKAP5 DNTTIP2 FBXO9 EML5 ATXN1 NUP210 DMD CACNA1A FAT4 FAT3 PCLO MAGEH1 HECTD4 GRIP1 IQCB1 AKAP13 CDH2 CDH4 | 1.39e-05 | 654 | 273 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SMG1 TOX MAPT EPB41L3 BIRC6 RYR2 SERPINI1 SALL1 EML5 HERC2 CACNA1B RELCH FAT4 ZBTB33 ANK2 NRCAM FAT3 RANBP6 MSL1 VAT1L ECPAS KANSL1 PAFAH1B1 CNTNAP4 CNTN3 CDH2 | 2.20e-05 | 818 | 273 | 26 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | TOX INSIG1 MC4R NCKAP5 DIP2A FAT1 SALL1 FBXO9 ATXN1 NUP210 DMD WNK2 CACNA1A ANK2 FAT3 PCLO MAGEH1 HECTD4 YBX2 IQCB1 LPIN2 TRAPPC10 AKAP13 CDH4 | 2.26e-05 | 722 | 273 | 24 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | AKAP8 MYO10 SANBR DNTTIP2 EML5 ATXN1 NUP210 DMD CACNA1A FAT3 PCLO GRIP1 IQCB1 CDH2 CDH4 | 2.47e-05 | 328 | 273 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | AKAP8 TOX MYO10 SANBR MC4R GBE1 NCKAP5 ADGRV1 FAT1 GSPT2 EML5 ATXN1 NUP210 DMD WNK2 CACNA1A ANK2 NRCAM FAT3 PCLO MAGEH1 HIPK2 FRYL YBX2 LPIN2 CDH2 CDH4 | 3.63e-05 | 893 | 273 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TOX INSIG1 MC4R NCKAP5 ADGRV1 SLC25A25 DIP2A FAT1 FBXO9 ATXN1 DMD WNK2 CACNA1A ANK2 FAT3 PCLO MAGEH1 HECTD4 YBX2 IQCB1 LPIN2 CNTN3 AKAP13 CDH4 | 3.89e-05 | 747 | 273 | 24 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | TPR SMG1 TOX MYO10 EPB41L3 BIRC6 AK5 RELCH FAT3 HIPK2 NUP214 GTPBP2 KANSL1 KANK4 | 5.65e-05 | 312 | 273 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TPR SMG1 MAPT MYO10 SLC38A5 EPB41L3 BIRC6 RYR2 ZCCHC14 HERC2 CACNA1B RELCH FAT4 ANK2 NRCAM FAT3 HIPK2 NUP214 RUNX1 ECPAS KANSL1 CNTNAP4 CDH2 DCP1A SON | 6.01e-05 | 818 | 273 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 7.32e-05 | 107 | 273 | 8 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | SMG1 MYO10 EPB41L3 BIRC6 RYR2 ZCCHC14 RELCH HIPK2 NUP214 KANSL1 DCP1A | 8.77e-05 | 209 | 273 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | TOX INSIG1 MC4R NCKAP5 ADGRV1 DIP2A FAT1 FBXO9 ATXN1 DMD WNK2 CACNA1A ANK2 FAT3 PCLO MAGEH1 HECTD4 VAT1L YBX2 IQCB1 LPIN2 TRAPPC10 CDH4 | 9.88e-05 | 743 | 273 | 23 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TOX SANBR MC4R NCKAP5 ADGRV1 DIP2A FAT1 FBXO9 EML5 ATXN1 DMD WNK2 CACNA1A FAT3 PCLO MAGEH1 HECTD4 HIPK2 YBX2 LPIN2 | 1.45e-04 | 614 | 273 | 20 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.51e-04 | 89 | 273 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | TOX INSIG1 MC4R NCKAP5 DIP2A FAT1 FBXO9 ATXN1 FAM216A DMD WNK2 CACNA1A ANK2 FAT3 PCLO MAGEH1 HECTD4 YBX2 IQCB1 LPIN2 TRAPPC10 CDH4 | 1.72e-04 | 721 | 273 | 22 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NRG1 AKAP8 TOX MYO10 INSIG1 SANBR ADGRV1 DNTTIP2 SALL1 EML5 ATXN1 NUP210 DMD WNK2 CACNA1A ANK2 NRCAM FAT3 PCLO GSN GRIP1 ZFYVE28 LGALSL IQCB1 CNTNAP4 CDH2 CDH4 | 1.79e-04 | 983 | 273 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR AKAP8 MYO10 SANBR GBE1 NCKAP5 ADGRV1 DIP2A SALL1 GSPT2 EML5 NUP210 NECTIN2 DMD WNK2 CACNA1A NRCAM FAT3 PCLO HIPK2 FRYL CCDC92 LPIN2 MACF1 TSHZ1 CDH2 CDH4 | 1.88e-04 | 986 | 273 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.91e-04 | 191 | 273 | 10 | gudmap_kidney_adult_Podocyte_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.94e-04 | 156 | 273 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | TOX INSIG1 MC4R NCKAP5 DIP2A FAT1 FBXO9 ATXN1 FAM216A DMD WNK2 CACNA1A ANK2 FAT3 PCLO MAGEH1 HECTD4 YBX2 IQCB1 LPIN2 TRAPPC10 CDH4 | 2.04e-04 | 730 | 273 | 22 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.05e-04 | 124 | 273 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MYO10 SANBR NCKAP5 EML5 NUP210 DMD FAT3 PCLO GRIP1 CDH2 CDH4 | 2.11e-04 | 231 | 273 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | TOX SANBR MC4R NCKAP5 ADGRV1 DIP2A FAT1 EML5 ATXN1 NUP210 DMD WNK2 CACNA1A NRCAM FAT3 PCLO MAGEH1 YBX2 IQCB1 LPIN2 CDH4 | 2.18e-04 | 683 | 273 | 21 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | NRG1 TOX MYO10 INSIG1 SANBR ADGRV1 SALL1 EML5 ATXN1 NUP210 DMD NRCAM FAT3 PCLO CNTNAP4 CDH2 CDH4 | 2.37e-04 | 493 | 273 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 2.75e-04 | 98 | 273 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SMG1 MED18 PRR23C MYO10 MCM3 ANKHD1 BIRC6 ZCCHC14 SERPINI1 KDR DMRT1 CNOT3 DPPA2 RNF17 KANSL1 PAFAH1B1 SLC25A44 ROBO2 DEPDC5 CDH2 TNS1 HTT HELLS | 3.20e-04 | 806 | 273 | 23 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.07e-04 | 210 | 273 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.44e-04 | 139 | 273 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SMG1 MED18 MOSPD2 MCM3 TKTL1 ANKHD1 BIRC6 RYR2 SERPINI1 EML5 C8G DMRT1 RELCH DPPA2 RUNX1 ECPAS RNF17 KANSL1 PAFAH1B1 IQCB1 DEPDC5 HELLS | 4.71e-04 | 776 | 273 | 22 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.91e-04 | 51 | 273 | 5 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_1000 | MAPT SERPINI1 EML5 CACNA1B ANK2 NRCAM MSL1 VAT1L CNTNAP4 CNTN3 | 5.27e-04 | 217 | 273 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_1000 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | ADAM19 NCKAP5 ACOX3 RYR2 DMD MYO18B WNK2 ANK2 TACC2 GRIP1 ROBO2 CDH2 ALPK2 | 2.22e-10 | 188 | 279 | 13 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | SLC38A5 CDH23 RYR2 NEO1 YAP1 KIF13B FAT4 FN1 RUNX1 SH3D19 MACF1 ROBO2 RORA | 3.96e-10 | 197 | 279 | 13 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 RYR2 FAT1 DMD USH2A FAT4 NRCAM FAT3 PCLO PKHD1L1 CNTNAP4 SPAG17 | 2.16e-09 | 184 | 279 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 RYR2 FAT1 DMD USH2A FAT4 NRCAM FAT3 PCLO PKHD1L1 CNTNAP4 SPAG17 | 2.16e-09 | 184 | 279 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 RYR2 FAT1 DMD USH2A FAT4 NRCAM FAT3 PCLO PKHD1L1 CNTNAP4 SPAG17 | 2.16e-09 | 184 | 279 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | CPAMD8 BPIFB1 NCKAP5 ADGRV1 FAT1 SERPINI1 KDR LNX1 WNK2 GRIP1 CNTN3 RORA | 2.60e-09 | 187 | 279 | 12 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | ADAM19 NCKAP5 ACOX3 RYR2 DMD MYO18B WNK2 ANK2 TACC2 GRIP1 CDH2 ALPK2 | 3.94e-09 | 194 | 279 | 12 | 89812fb164065041357bb37a3c2d87028ec3de4e |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TPR SMG1 BIRC6 TRIM22 ARID1B DYNC1H1 FRYL KANSL1 MACF1 AKAP13 HERC5 SON | 5.55e-09 | 200 | 279 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | TPR GARIN5A FAT1 PXDN CCDC14 HSPG2 APBB2 FRYL ZNF772 NHSL1 DDX20 | 1.04e-08 | 169 | 279 | 11 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | NCKAP5 RYR2 FAT1 DMD MYO18B ANK2 ARHGEF12 TACC2 AKAP13 CDH2 ALPK2 | 3.49e-08 | 190 | 279 | 11 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | EPB41L3 ANKHD1 BIRC6 ARID1B ATXN1 RUNX1 KANSL1 SBF2 GPCPD1 AKAP13 PPP6R3 | 4.10e-08 | 193 | 279 | 11 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.10e-08 | 193 | 279 | 11 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.56e-08 | 195 | 279 | 11 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO10 EPB41L3 DYNC1H1 CACNA1A PCLO FRYL MACF1 ROBO2 TSHZ1 CDH2 SON | 4.56e-08 | 195 | 279 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.06e-08 | 197 | 279 | 11 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.06e-08 | 197 | 279 | 11 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | BIRC6 ARID1B ATXN1 DMD APBB2 GRIP1 KANSL1 SBF2 RORA MBD5 PPP6R3 | 5.61e-08 | 199 | 279 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.78e-08 | 159 | 279 | 10 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 177 | 279 | 10 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.40e-07 | 182 | 279 | 10 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.79e-07 | 185 | 279 | 10 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.93e-07 | 186 | 279 | 10 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-07 | 186 | 279 | 10 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | NCKAP5 RYR2 DMD MYO18B ANK2 ARHGEF12 TACC2 AKAP13 CDH2 ALPK2 | 3.40e-07 | 189 | 279 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.57e-07 | 190 | 279 | 10 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.57e-07 | 190 | 279 | 10 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.74e-07 | 191 | 279 | 10 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.74e-07 | 191 | 279 | 10 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-07 | 191 | 279 | 10 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 EPB41L3 ARID1B ATXN1 SH3D19 SBF2 MACF1 AKAP13 RORA MBD5 | 3.93e-07 | 192 | 279 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.12e-07 | 193 | 279 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-07 | 193 | 279 | 10 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.32e-07 | 194 | 279 | 10 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.32e-07 | 194 | 279 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.53e-07 | 195 | 279 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPB41L3 DYNC1H1 CACNA1A PCLO FRYL MACF1 ROBO2 TSHZ1 CDH2 SON | 4.53e-07 | 195 | 279 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 4.75e-07 | 196 | 279 | 10 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.75e-07 | 196 | 279 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.75e-07 | 196 | 279 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-07 | 197 | 279 | 10 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.98e-07 | 197 | 279 | 10 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.98e-07 | 197 | 279 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.98e-07 | 197 | 279 | 10 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-07 | 197 | 279 | 10 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 198 | 279 | 10 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-07 | 198 | 279 | 10 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.21e-07 | 198 | 279 | 10 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 198 | 279 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.21e-07 | 198 | 279 | 10 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 5.46e-07 | 199 | 279 | 10 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.46e-07 | 199 | 279 | 10 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.46e-07 | 199 | 279 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ITIH3 SPTBN5 CASKIN2 AK5 ZBTB33 NRCAM FAT3 TBL3 KANK4 CNTNAP4 | 5.46e-07 | 199 | 279 | 10 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.71e-07 | 200 | 279 | 10 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.71e-07 | 200 | 279 | 10 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-07 | 200 | 279 | 10 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.71e-07 | 200 | 279 | 10 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.71e-07 | 200 | 279 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.53e-07 | 159 | 279 | 9 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-07 | 160 | 279 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.94e-07 | 160 | 279 | 9 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.94e-07 | 160 | 279 | 9 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-07 | 160 | 279 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 9.27e-07 | 163 | 279 | 9 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 165 | 279 | 9 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 165 | 279 | 9 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-06 | 166 | 279 | 9 | 971ee6602a1e751f453f9d823295e63dadce62bf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 178 | 279 | 9 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 178 | 279 | 9 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 2.11e-06 | 180 | 279 | 9 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 181 | 279 | 9 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 181 | 279 | 9 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.31e-06 | 182 | 279 | 9 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.31e-06 | 182 | 279 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.64e-06 | 185 | 279 | 9 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.02e-06 | 188 | 279 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 189 | 279 | 9 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.15e-06 | 189 | 279 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 190 | 279 | 9 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.43e-06 | 191 | 279 | 9 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 3.58e-06 | 192 | 279 | 9 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-06 | 192 | 279 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-06 | 192 | 279 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-06 | 193 | 279 | 9 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-06 | 193 | 279 | 9 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 193 | 279 | 9 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.74e-06 | 193 | 279 | 9 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.74e-06 | 193 | 279 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.90e-06 | 194 | 279 | 9 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-06 | 194 | 279 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-06 | 195 | 279 | 9 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-06 | 195 | 279 | 9 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-06 | 195 | 279 | 9 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 195 | 279 | 9 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-06 | 195 | 279 | 9 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.07e-06 | 195 | 279 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.07e-06 | 195 | 279 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.07e-06 | 195 | 279 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.07e-06 | 195 | 279 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-06 | 195 | 279 | 9 | 44f67437ea65d530133a0240b17f9860d9cc0e99 | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | AKAP8 L2HGDH ACOX3 KAZN FN1 HIPK2 ECPAS ATP8B2 PCSK7 LRP6 AKAP13 HCFC1 SLC26A6 | 1.11e-06 | 199 | 278 | 13 | 7212_DN |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | ZBTB17 MPDZ ACOX3 TECPR2 CASKIN2 NUP210 CNOT3 LGALSL CEP72 SOCS5 SLC25A44 HCFC1 | 4.81e-06 | 193 | 278 | 12 | 6981_DN |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | MED18 MOSPD2 ACOX3 ATXN1 TECPR2 NUP210 HSPBAP1 GTPBP2 IQCB1 TRAPPC10 SLC25A44 HCFC1 | 5.07e-06 | 194 | 278 | 12 | 7406_DN |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | TPR RBM10 TMC6 APBB2 FAAP100 MED15 MLH3 LRP6 SLC25A44 DHX34 TNS1 HCFC1 | 5.63e-06 | 196 | 278 | 12 | 5833_DN |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A | EXPH5 TMC6 L2HGDH NUP210 FN1 ARHGEF12 LGALSL SOCS5 POLI PCSK7 LRP6 SLC26A6 | 6.24e-06 | 198 | 278 | 12 | 7210_DN |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A | DBNDD2 TRIM22 NUP160 SELPLG FAAP100 ATP10D ARHGEF40 VWA5A DEPDC5 DHX34 HTT | 2.33e-05 | 190 | 278 | 11 | 2189_DN |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A | NRG1 TRIM22 ACOX3 MOCS1 CACNA1A ANK2 APBB2 RUNX1 VWA5A CNGB3 LRP6 | 2.83e-05 | 194 | 278 | 11 | 6712_UP |
| Drug | nocodazole; Up 200; 1uM; MCF7; HG-U133A | ZBTB17 UBE2G2 ATXN1 CASKIN2 NFKB2 FRYL TACC2 AARSD1 GTPBP2 PCSK7 CDH2 | 2.96e-05 | 195 | 278 | 11 | 621_UP |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; HL60; HT_HG-U133A | MYO10 EXPH5 PCDH12 KAZN FN1 ANK2 RUNX1 NR1D1 MLH3 DHX34 TNS1 | 3.11e-05 | 196 | 278 | 11 | 2710_DN |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A | MAPT ZCCHC14 FBXO9 KAZN FKBP15 APBB2 BTBD2 NR1D1 CDH2 HCFC1 AHNAK2 | 3.41e-05 | 198 | 278 | 11 | 1541_UP |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | EXPH5 FBXO9 NFKB2 KIF13B FN1 PCLO CEP72 VWA5A LPIN2 TNS1 AHNAK2 | 3.41e-05 | 198 | 278 | 11 | 4842_UP |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | MED18 MPDZ FBXO9 CASKIN2 NUP210 NUP160 HSPG2 PCLO ATP8B2 PAFAH1B1 AKAP13 | 3.41e-05 | 198 | 278 | 11 | 2062_DN |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | RBM10 GMEB2 RRP12 FAAP100 MLH3 CEP72 VWA5A CNGB3 TRAPPC10 HCFC1 SLC26A6 | 3.41e-05 | 198 | 278 | 11 | 5295_UP |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | ACOX3 RRP12 KAZN CACNA1A ANK2 RUNX1 FAAP100 TBL3 MLH3 CEP72 LRP6 | 3.57e-05 | 199 | 278 | 11 | 3140_DN |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; HL60; HT_HG-U133A | EXPH5 SUCLG1 PTGIR RYR1 SELPLG KIF13B RUNX1 CEP72 SLC25A44 MACF1 AKAP13 | 3.57e-05 | 199 | 278 | 11 | 2408_UP |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A | TRIM22 ACOX3 RRP12 NUP210 NECTIN2 KIF13B FN1 TBL3 INTS5 HTT SON | 3.57e-05 | 199 | 278 | 11 | 1588_DN |
| Disease | epilepsy (implicated_via_orthology) | MAPT DHX9 KCNA2 BSN DYNC1H1 CACNA1A CACNA1B ANK2 NRCAM SBF2 DEPDC5 | 2.97e-07 | 163 | 266 | 11 | DOID:1826 (implicated_via_orthology) |
| Disease | cortical thickness | CPAMD8 MAPT NCKAP5 ADGRV1 NEO1 ARID1B TACC3 LNX1 WNK2 HSPG2 GALR3 FAT3 SMARCAL1 ARHGEF12 TACC2 GRIP1 NHSL1 GTPBP2 ARHGEF40 KANSL1 PAFAH1B1 MACF1 ROBO2 RORA TNS1 | 2.90e-05 | 1113 | 266 | 25 | EFO_0004840 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.39e-05 | 145 | 266 | 8 | DOID:1289 (implicated_via_orthology) | |
| Disease | Intellectual Disability | L2HGDH PCDH12 KCNA2 TAF2 DYNC1H1 CACNA1B SHANK3 GTPBP2 KANSL1 MACF1 RORA ZBTB11 CDH2 HTT | 6.19e-05 | 447 | 266 | 14 | C3714756 |
| Disease | Colorectal Carcinoma | CPAMD8 ADAM19 RBM10 FAT1 SH3TC1 YAP1 ODAM KDR DMD VWA2 RELCH FN1 ANK2 NRCAM ITPRID1 MLH3 ZZZ3 SPAG17 | 7.73e-05 | 702 | 266 | 18 | C0009402 |
| Disease | Malformations of Cortical Development, Group II | 8.10e-05 | 2 | 266 | 2 | C1837249 | |
| Disease | Malignant neoplasm of breast | NRG1 NCOA6 AKAP8 EPB41L3 ZCCHC14 ARID1B PER2 YAP1 NECTIN2 KDR HERC2 DMD FN1 ANK2 NRCAM SMARCAL1 TACC2 NUP214 GSN NUP133 MACF1 CDH2 TNS1 | 1.24e-04 | 1074 | 266 | 23 | C0006142 |
| Disease | breast carcinoma | MAPT PPRC1 MC4R BPIFB1 EPB41L3 ARID1B ATXN1 DMD RBMS1 ARHGEF12 TACC2 YBX2 KANSL1 SBF2 SYT14 PCSK7 SLC25A44 RORA BRSK1 SPAG17 CDH2 TNS1 | 1.55e-04 | 1019 | 266 | 22 | EFO_0000305 |
| Disease | serum VEGFR2 concentration measurement | 2.41e-04 | 3 | 266 | 2 | EFO_0006795 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.41e-04 | 3 | 266 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.41e-04 | 3 | 266 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.41e-04 | 3 | 266 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Weight Gain | 3.31e-04 | 102 | 266 | 6 | C0043094 | |
| Disease | migraine (implicated_via_orthology) | 4.80e-04 | 4 | 266 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Triple Negative Breast Neoplasms | 4.80e-04 | 4 | 266 | 2 | C3539878 | |
| Disease | Nodular glomerulosclerosis | 5.03e-04 | 41 | 266 | 4 | C0017667 | |
| Disease | hair colour measurement | NRG1 ZBTB17 INSIG1 L2HGDH ADGRV1 NEO1 PXDN UBE2G2 HERC2 LNX1 RANBP6 MSL1 SBF2 AKAP13 PPP6R3 | 5.13e-04 | 615 | 266 | 15 | EFO_0007822 |
| Disease | Diabetic Nephropathy | 6.60e-04 | 44 | 266 | 4 | C0011881 | |
| Disease | hip geometry | 6.60e-04 | 44 | 266 | 4 | EFO_0004685 | |
| Disease | Liver Cirrhosis, Experimental | NRG1 DBNDD2 TTC36 EXTL1 FAT1 FBXO9 PXDN NFE2L2 NECTIN2 RELL1 C8G HJV ATP10D GSN LGALSL ROBO2 HELLS | 7.20e-04 | 774 | 266 | 17 | C0023893 |
| Disease | feeling miserable measurement | 7.50e-04 | 79 | 266 | 5 | EFO_0009598 | |
| Disease | Ischemic stroke | 7.73e-04 | 324 | 266 | 10 | HP_0002140 | |
| Disease | selective IgA deficiency disease | 7.82e-04 | 46 | 266 | 4 | EFO_1001929 | |
| Disease | Anterior segment mesenchymal dysgenesis | 7.95e-04 | 5 | 266 | 2 | C1862839 | |
| Disease | frontal fibrosing alopecia | 9.20e-04 | 48 | 266 | 4 | EFO_0009855 | |
| Disease | alcohol consumption measurement | MAPT GBE1 NCKAP5 ADGRV1 BIRC6 SPTBN5 NFATC2 ATXN1 NFE2L2 AK5 NUP160 CACNA1A PCLO DDR2 VAT1L GRIP1 INTS5 ZZZ3 KANSL1 SYT14 CDH4 HTT PPP6R3 | 9.40e-04 | 1242 | 266 | 23 | EFO_0007878 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 9.58e-04 | 276 | 266 | 9 | EFO_0004612, EFO_0020943 | |
| Disease | puberty onset measurement | 9.72e-04 | 125 | 266 | 6 | EFO_0005677 | |
| Disease | reaction time measurement | AKAP8 MAPT LRRK2 GBE1 NCKAP5 AK5 HECTD4 TACC2 CCDC92 KANSL1 CEP72 PAFAH1B1 POLI TSHZ1 CDH2 | 1.02e-03 | 658 | 266 | 15 | EFO_0008393 |
| Disease | Paratuberculosis | 1.19e-03 | 6 | 266 | 2 | C0030524 | |
| Disease | Lissencephaly | 1.19e-03 | 6 | 266 | 2 | C0266463 | |
| Disease | cortical surface area measurement | CPAMD8 MAPT NCKAP5 ADGRV1 NEO1 ARID1B TACC3 LNX1 WNK2 CACNA1A FAT3 PRSS55 HIPK2 ARHGEF12 FRYL GRIP1 NHSL1 KANSL1 PAFAH1B1 MACF1 ROBO2 RORA SPAG17 TNS1 | 1.21e-03 | 1345 | 266 | 24 | EFO_0010736 |
| Disease | reticulocyte count | NCOA6 MAPT TMC6 TKTL1 GMEB2 BIRC6 FAT1 ATXN1 YAP1 TAF2 BSN RBMS1 HECTD4 EXOSC3 CCDC92 SCARF1 KANSL1 RORA DEPDC5 TNS1 | 1.37e-03 | 1045 | 266 | 20 | EFO_0007986 |
| Disease | reticulocyte measurement | MAPT TMC6 TKTL1 BIRC6 FAT1 ATXN1 AK5 BSN GNL1 RBMS1 HECTD4 CCDC92 ECPAS SCARF1 KANSL1 SBF2 LPIN2 AKAP13 DEPDC5 TNS1 | 1.49e-03 | 1053 | 266 | 20 | EFO_0010700 |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 NCKAP5 NEO1 TACC3 LNX1 WNK2 FAT3 NHSL1 KANSL1 MACF1 ROBO2 RORA TNS1 | 1.58e-03 | 550 | 266 | 13 | EFO_0004346, EFO_0004464 |
| Disease | ergothioneine measurement | 1.62e-03 | 26 | 266 | 3 | EFO_0021163 | |
| Disease | age at diagnosis, osteoarthritis | 1.65e-03 | 7 | 266 | 2 | EFO_0004918, MONDO_0005178 | |
| Disease | Developmental regression | 1.65e-03 | 7 | 266 | 2 | C1836830 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.65e-03 | 7 | 266 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.65e-03 | 7 | 266 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | inter-alpha-trypsin inhibitor heavy chain h4 measurement | 1.65e-03 | 7 | 266 | 2 | EFO_0020481 | |
| Disease | Profound Mental Retardation | 1.68e-03 | 139 | 266 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.68e-03 | 139 | 266 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.68e-03 | 139 | 266 | 6 | C0025363 | |
| Disease | neutrophil count | CPAMD8 ADAM19 MOSPD2 MAPT CDH23 DIP2A KCNA2 SALL1 ATXN1 RRP12 LNX1 NUP160 CACNA1A RBMS1 HECTD4 ARHGEF12 VWA7 SH3D19 SBF2 POLI AKAP13 YY1AP1 HTT HELLS | 1.73e-03 | 1382 | 266 | 24 | EFO_0004833 |
| Disease | Inhalant adrenergic use measurement | 1.80e-03 | 96 | 266 | 5 | EFO_0009941 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.12e-03 | 60 | 266 | 4 | EFO_0022233 | |
| Disease | beta-secretase 1 measurement | 2.19e-03 | 8 | 266 | 2 | EFO_0009179 | |
| Disease | Embryonal Rhabdomyosarcoma | 2.19e-03 | 8 | 266 | 2 | C0206656 | |
| Disease | memory impairment | 2.19e-03 | 8 | 266 | 2 | EFO_0001072 | |
| Disease | Pena-Shokeir syndrome type I | 2.19e-03 | 8 | 266 | 2 | C1276035 | |
| Disease | Anterior segment dysgenesis | 2.19e-03 | 8 | 266 | 2 | cv:C1862839 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 2.23e-03 | 29 | 266 | 3 | DOID:332 (is_marker_for) | |
| Disease | Movement Disorders | 2.23e-03 | 29 | 266 | 3 | C0026650 | |
| Disease | blood cobalt measurement | 2.25e-03 | 101 | 266 | 5 | EFO_0007577 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.37e-03 | 315 | 266 | 9 | EFO_0004612, EFO_0008591 | |
| Disease | cholesteryl ester measurement | 2.42e-03 | 257 | 266 | 8 | EFO_0010351 | |
| Disease | Epileptic encephalopathy | 2.46e-03 | 30 | 266 | 3 | C0543888 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.46e-03 | 150 | 266 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | body weight | PDXDC1 NRG1 MC4R ADGRV1 NFATC2 KAZN DMD LNX1 NUP160 CACNA1B RELCH NRCAM RBMS1 WNT9A HECTD4 ARHGEF12 VAT1L SYT14 CNTNAP4 RORA DDX20 ADAMTS14 | 2.53e-03 | 1261 | 266 | 22 | EFO_0004338 |
| Disease | carcinoma (implicated_via_orthology) | 2.68e-03 | 64 | 266 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | corticobasal degeneration disorder | 2.80e-03 | 9 | 266 | 2 | MONDO_0022308 | |
| Disease | cognitive disorder (is_implicated_in) | 2.80e-03 | 9 | 266 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | red blood cell density measurement | PDXDC1 NRG1 MAPT TMC6 ADGRV1 ITIH3 ARID1B SALL1 CCDC92 RUNX1 ATP8B2 ARHGEF40 KANSL1 SBF2 POLI AKAP13 RORA | 2.80e-03 | 880 | 266 | 17 | EFO_0007978 |
| Disease | worry measurement | 2.81e-03 | 154 | 266 | 6 | EFO_0009589 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.86e-03 | 264 | 266 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | Large cell carcinoma of lung | 2.96e-03 | 32 | 266 | 3 | C0345958 | |
| Disease | Dupuytren Contracture | 3.01e-03 | 108 | 266 | 5 | EFO_0004229 | |
| Disease | Disorder of eye | 3.23e-03 | 212 | 266 | 7 | C0015397 | |
| Disease | urate measurement | NRG1 NCOA6 MC4R ADGRV1 EPB41L3 BIRC6 NEO1 AK5 NECTIN2 MYO18B DDR2 HECTD4 VARS2 SBF2 AKAP13 MBD5 CCDC17 | 3.32e-03 | 895 | 266 | 17 | EFO_0004531 |
| Disease | synophrys measurement | 3.35e-03 | 68 | 266 | 4 | EFO_0007906 | |
| Disease | Abnormality of refraction | SMG1 MAPT TKTL1 TRUB1 BIRC6 RBMS1 FAT3 PCLO RUNX1 CNGB3 SYT14 AKAP13 RORA CDH2 | 3.40e-03 | 673 | 266 | 14 | HP_0000539 |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 3.47e-03 | 10 | 266 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 3.47e-03 | 10 | 266 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 3.47e-03 | 10 | 266 | 2 | C1631597 | |
| Disease | Spinocerebellar Ataxia Type 2 | 3.53e-03 | 34 | 266 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 3.53e-03 | 34 | 266 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 3.53e-03 | 34 | 266 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 3.53e-03 | 34 | 266 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 3.53e-03 | 34 | 266 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 3.53e-03 | 34 | 266 | 3 | C0087012 | |
| Disease | brain connectivity measurement | 3.62e-03 | 400 | 266 | 10 | EFO_0005210 | |
| Disease | pneumonia, COVID-19 | 3.65e-03 | 113 | 266 | 5 | EFO_0003106, MONDO_0100096 | |
| Disease | dentures | 3.71e-03 | 70 | 266 | 4 | EFO_0010078 | |
| Disease | dental caries, dentures | 3.71e-03 | 70 | 266 | 4 | EFO_0003819, EFO_0010078 | |
| Disease | retinal detachment, retinal break | 3.83e-03 | 35 | 266 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | Spinocerebellar Ataxia Type 4 | 3.83e-03 | 35 | 266 | 3 | C0752122 | |
| Disease | uric acid measurement | NRG1 TMC6 MC4R ADGRV1 EPB41L3 BIRC6 NFATC2 FAT4 RBMS1 FAT3 HECTD4 SBF2 AKAP13 | 3.84e-03 | 610 | 266 | 13 | EFO_0004761 |
| Disease | neuroimaging measurement | PDXDC1 MAPT NCKAP5 NEO1 TACC3 DMRT1 LNX1 WNK2 FAT3 ARHGEF12 FRYL TACC2 NHSL1 KANSL1 MACF1 ROBO2 RORA TNS1 HTT | 4.02e-03 | 1069 | 266 | 19 | EFO_0004346 |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 4.15e-03 | 36 | 266 | 3 | EFO_0006325 | |
| Disease | Semantic-Pragmatic Disorder | 4.22e-03 | 11 | 266 | 2 | C0454655 | |
| Disease | response to ondansetron, QT interval | 4.22e-03 | 11 | 266 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | ovarian carcinoma, COVID-19 | 4.22e-03 | 11 | 266 | 2 | EFO_0001075, MONDO_0100096 | |
| Disease | nucleus accumbens volume change measurement | 4.22e-03 | 11 | 266 | 2 | EFO_0021493 | |
| Disease | Auditory Processing Disorder, Central | 4.22e-03 | 11 | 266 | 2 | C0751257 | |
| Disease | Language Delay | 4.22e-03 | 11 | 266 | 2 | C0023012 | |
| Disease | Language Development Disorders | 4.22e-03 | 11 | 266 | 2 | C0023014 | |
| Disease | Cognitive impairment | 4.22e-03 | 11 | 266 | 2 | HP_0100543 | |
| Disease | Speech Delay | 4.22e-03 | 11 | 266 | 2 | C0241210 | |
| Disease | memory performance | NRG1 ITIH3 NEO1 PXDN AK5 NECTIN2 KAZN DPPA2 ARHGEF12 ZFYVE28 | 4.22e-03 | 409 | 266 | 10 | EFO_0004874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEVSPLSAANMSIAV | 746 | O00555 | |
| MAVVPASLSGQDVGS | 1 | Q9H993 | |
| AEASRMQVSEGSPEE | 1001 | Q5RHP9 | |
| EMTFGAQASVATEPQ | 41 | Q96LX7 | |
| MGLADVVAADPATAS | 1386 | Q5SNV9 | |
| EATTLHVAPQGTAMA | 71 | P07360 | |
| QMALEEVSVSDPLAS | 156 | Q9HB65 | |
| EEQLASFAMPGDTLS | 801 | Q8TER5 | |
| MSEVLPADSGVDTLA | 1 | Q92870 | |
| PSSVSVEVSADGVNM | 3236 | Q9NR09 | |
| VEVSADGVNMLPLST | 3241 | Q9NR09 | |
| EAQATIRMDTSASGP | 136 | Q8TDL5 | |
| GSSGMEVDAAVVPSV | 16 | Q7L5N1 | |
| MASTVEGGDTALLPE | 1 | O15254 | |
| MAAEAESAQTRVAPA | 656 | O43823 | |
| QSISEANDETMSPGV | 741 | Q86TB3 | |
| ESNAVPIDTTIIMNG | 586 | Q9H013 | |
| DSSDMVPAAEVVGVA | 41 | P0C2W7 | |
| PMLVTSEDDAVTAAQ | 346 | Q9BX10 | |
| MPVSLDGDTNTSTQE | 61 | Q2KHT4 | |
| ILASDMGVPQLSSSV | 966 | Q6V0I7 | |
| VLTTIMAADPDEGAN | 1546 | Q6V0I7 | |
| GMPTDQESLSSGDAV | 431 | Q12802 | |
| AGMDISFPETTVAVA | 5131 | Q8WXG9 | |
| SVAVDGQMASAAPLL | 466 | Q9C0A0 | |
| LDTPSMTAEQVAAIE | 141 | Q9BTE6 | |
| PAMVNSSAASVGLAD | 1071 | Q8NFD5 | |
| GADVNAINEASMTPL | 191 | A6NGH8 | |
| SSAMVGEDVGSLALE | 466 | Q9P209 | |
| EASGALAAVATAMPA | 6 | Q9UHI6 | |
| LSEDGAAMAVEPTQI | 1936 | P11532 | |
| STDMEASGAAPAIVT | 496 | P54253 | |
| NLGSTETLEEMPSGS | 191 | Q9NPI6 | |
| VAEVSPMSAANISIA | 741 | Q00975 | |
| TPVGSSVTQLLAQDM | 46 | Q9H251 | |
| SNTRGMEEASAPGII | 736 | Q49A88 | |
| VDPVLADRSATEMSG | 161 | A6NDY2 | |
| VIMELLSVASPDGAS | 801 | Q9P241 | |
| ADETSLGSVMAPLVQ | 416 | Q8WXS8 | |
| ASVQRAVAMSSGDVP | 186 | O43918 | |
| EEVASSLTLQPMTGI | 1431 | Q9NZN5 | |
| MEEQAAFLVGSATPR | 571 | Q16853 | |
| AVTLAIGDGANDVSM | 826 | P98198 | |
| MAERAAISSGIEDPV | 546 | O75175 | |
| SGPAAMASQVLTQSA | 366 | Q9UKD1 | |
| EASLEPGADSVSMQA | 481 | P98175 | |
| VSGLLGSDQPDSEMT | 241 | Q9H714 | |
| QPAESRVSGISMDVA | 1096 | P98160 | |
| AHMQTTAVPVEEASG | 371 | P29558 | |
| VQATSSPMALGANAT | 201 | Q6ZVN8 | |
| SSVAIMPNGDHIVSA | 196 | P43034 | |
| VDPVLADRSATEMSG | 161 | A6NKC0 | |
| ESNEIITGMPASTEG | 131 | Q02297 | |
| IAEDSGQPMLASSVS | 536 | Q9NPG4 | |
| VATQEAASEPVAEGM | 531 | Q9HCC9 | |
| GSLMEGTPQISSEES | 2216 | Q01484 | |
| SPVSGSMQETQLSLE | 1476 | Q8N7Z5 | |
| SILSMTAQDPDSGDN | 501 | Q9Y5G9 | |
| QAISPELSGAMVVGD | 1476 | Q8TEM1 | |
| TVQEPQGSMSIAASL | 1171 | Q9P260 | |
| VSVDQTATPMLDGTS | 1111 | O75140 | |
| AFDENVPIGTTVMSL | 471 | Q14517 | |
| TVMSLSAVDPDEGEN | 481 | Q14517 | |
| PVGSSVIFMNSTDLD | 731 | Q14517 | |
| SLPQELMAEAQAGTT | 1586 | P51610 | |
| EPMDTSEAAATVTQA | 1651 | P51610 | |
| IMTVSPGAEDLVTSQ | 10726 | Q8WXI7 | |
| PVAGSAVIMDALNSL | 296 | Q13469 | |
| AVIMDALNSLATDSP | 301 | Q13469 | |
| ASSVAGPNSESMIFE | 491 | Q8WUM0 | |
| GSEAPAMVEQLDTAV | 11 | Q9NRZ9 | |
| MTVATGDPADEAAAL | 1 | P16389 | |
| VMGIVDLNPESFAIS | 56 | Q3ZCW2 | |
| EPTFNAEAMATALGI | 646 | Q674X7 | |
| TVIPETMAGTQQLAD | 736 | Q9H2X6 | |
| QASEASETPMAASVV | 26 | Q9H213 | |
| APTNLSNLGTMDITD | 2406 | Q2M2H8 | |
| AQDNGATIMPIITES | 156 | Q86T24 | |
| FETGPAMASRQVDIA | 1151 | Q92823 | |
| TEAEMENLPLNTGSS | 691 | Q6ZRS4 | |
| AAGSSDLDPSMILDT | 326 | Q9Y6K8 | |
| PAATSSIAISGMIAD | 441 | Q9H9P8 | |
| LPDSSMGEEQNSSIS | 1706 | Q86WG5 | |
| MSGGQIPDEDITASS | 36 | Q16832 | |
| IGQTSDISSPELMGV | 1071 | O95714 | |
| STVAIPAINDSSAAM | 96 | Q6ZU64 | |
| IDDATMSDGLPALVT | 2121 | Q2LD37 | |
| ASTLMSVQPEADTQG | 361 | Q9UPA5 | |
| SAGVVPTSQSLADMQ | 606 | Q5VYK3 | |
| IQSSPMTVISEGEGE | 1521 | Q5SYE7 | |
| EPLVSLEGSNSAVTM | 116 | Q8IYD1 | |
| LEGSNSAVTMELSEP | 121 | Q8IYD1 | |
| SAVTMELSEPVVENG | 126 | Q8IYD1 | |
| VPLQEDVDMSSGSSG | 26 | O15055 | |
| AIPAGMEADLSQLSE | 36 | Q9Y6V0 | |
| ESLVGAEHAMTTPLQ | 2811 | Q9Y6V0 | |
| LDGPLTDSMEAVAFN | 261 | Q16549 | |
| SEQQIGSLDSPSGML | 991 | Q9UHC1 | |
| MAATSGTDEPVSGEL | 1 | Q9BVG4 | |
| ASGITNQMSIDELSP | 501 | Q01064 | |
| PASGLTVMDLEAEGT | 441 | Q6P996 | |
| ETSVAQVAPVDLDGM | 166 | Q16236 | |
| PAVSQVMGSLSSNFE | 211 | A6NFA0 | |
| LQLTDPVSSGVTHMD | 1446 | O94915 | |
| SQMSGVEAAASDPSE | 871 | Q5T1M5 | |
| EMINVSVSGPSLLAA | 36 | O15503 | |
| QLGTAPEIAVMSTGE | 206 | A1E959 | |
| ASVSDPMNALQSLTG | 76 | Q96RN5 | |
| AILESSPIMEAFGNA | 196 | Q9HD67 | |
| GESSFDINNIVIPMS | 856 | Q7Z3B3 | |
| GEVTVEMNAAPGTDL | 296 | Q2M2I5 | |
| ETAPAVAAAITQEGM | 931 | O94854 | |
| AAATISLMTDEPGLD | 166 | Q8TBB1 | |
| AAMDGSERTTLVPNV | 776 | O75581 | |
| EGSNTSLDIMAAVVP | 471 | Q5S007 | |
| ADGTLETSPDVVMAL | 261 | P35658 | |
| APTLQEMASVEAAVS | 1341 | Q8NEV8 | |
| DASISLGESVSDMAP | 1166 | Q96RT7 | |
| EVTMGVAASSPALEL | 146 | Q6IPT2 | |
| VLVEQQTDSAMEPTG | 336 | P36915 | |
| VDPVLADRSAAEMSG | 161 | P0DV74 | |
| MLVGQVTGDDTISPS | 86 | Q8NGX1 | |
| MLVGQVTGDDTISPS | 86 | Q8NH03 | |
| MSQDAPDVFTVSVGN | 706 | Q9UKK3 | |
| GEPLDNAETASVSDM | 3131 | Q9Y4D8 | |
| LMPSSVAGETSVLAV | 461 | Q68DK7 | |
| VDPVLADRSAAEMSG | 161 | P0DV73 | |
| MVTEQATQGSSAPDL | 811 | Q0VG06 | |
| TFQGSELSPELQAAM | 666 | Q8WXE0 | |
| VDPVLADRSAAEMSG | 161 | P0DV76 | |
| PTGVEMEALTSAAVA | 586 | Q9NZB8 | |
| LSVVAPAGQDMVSDD | 171 | Q9BUE0 | |
| APASAEAMVDEGQLA | 11 | Q9UMY1 | |
| VPLAQISAGEAHSMA | 191 | Q9UII4 | |
| DAMPLGSAVDILATD | 516 | P25205 | |
| LAEMASLPEASGSEA | 1126 | Q14686 | |
| MEVSAETLFGNVPSL | 201 | Q3KR16 | |
| VDPVLADRSAAEMSG | 161 | A6NJQ4 | |
| GSLQVAMEDSSRVSP | 101 | P20393 | |
| SFQMSEGSEAAVIPL | 211 | Q15884 | |
| MADAQNISLDSPGSV | 1 | O60755 | |
| MAAGSEATTPVIVAA | 1 | Q96EW2 | |
| GSDIEMLNSVTPTDS | 21 | Q9ULG6 | |
| DSITIAEDVSGMPAL | 406 | Q04446 | |
| MDLNDGTQASSPISD | 546 | P42858 | |
| NAVALLPENDTGESM | 36 | Q9NPB8 | |
| MSETVPAASASAGVA | 1 | P22492 | |
| SSGEEAAPVTAMAAE | 16 | Q14241 | |
| AAPVTAMAAESALQV | 21 | Q14241 | |
| MFELAPGVSSSNLEN | 51 | Q9UK97 | |
| PIGSISSMEVNVDTL | 146 | Q9BQY9 | |
| LAPDSSSVVVSGLMV | 1861 | P02751 | |
| EGPLDVSMAATNLEN | 11 | Q53HC0 | |
| HAVMDISLPTGISAN | 1421 | P01031 | |
| ALSSGPQDTAGMIEI | 986 | Q8IZJ3 | |
| TQLAGPDMEVGATDL | 86 | Q96L46 | |
| TDGENLADPMSINIS | 656 | Q8TDW7 | |
| VQAVDSGIPAMSSTA | 3416 | Q8TDW7 | |
| GITDLTDQTSTVDPM | 246 | Q9NP62 | |
| TAGVTISIMDINEAP | 491 | P55283 | |
| SNGELDPDVLESMAS | 311 | Q8TDC3 | |
| MANTTGEPEEVSGAL | 1 | Q9NS66 | |
| MSVPLLTDAATVSGA | 6 | O95372 | |
| LAVADMLVSVSNGSE | 86 | P32245 | |
| ILQPSAGEGDMSSIN | 941 | Q9P267 | |
| GSPMSDVVSRELHAQ | 471 | Q15051 | |
| ALPDMEVVGLNFSSA | 2611 | Q14204 | |
| AVMITPLASAETNED | 861 | Q5T7N3 | |
| QSPVAAVEAFLMDEG | 91 | Q8IXV7 | |
| GAGTMSVSLVADENP | 306 | P06396 | |
| QVGDSADMSATAPSI | 1436 | Q05BV3 | |
| SMSIPIAGESESLQE | 156 | Q5T8I3 | |
| MLETADGVPVNSRVS | 256 | Q14689 | |
| SSDIAAASAPEMLIQ | 181 | Q8WUB2 | |
| MDSVATASGPLLVEV | 241 | Q9Y3R0 | |
| NGGMATTSTEIELPD | 151 | Q9BX70 | |
| SGMAEISAVLEAAQT | 386 | Q14147 | |
| MELADVGAAASSQGV | 26 | Q9UNA4 | |
| GSSPNMNILAAAVTT | 336 | Q9NSC2 | |
| GMQGSTPLDVAAASV | 2266 | P21817 | |
| GSTPLDVAAASVMDN | 2236 | Q92736 | |
| MAEPASVAAESLAGS | 1 | Q9NQT5 | |
| EMAVPAAGDESISSL | 291 | Q5VV67 | |
| LAMDPDSGQVTAVGT | 486 | P22223 | |
| VMTVTAIDADDPNAL | 286 | P19022 | |
| RITLAPSNMDVSVGE | 501 | Q9P232 | |
| TDLEPGVLMSAQTIT | 996 | Q9Y2J2 | |
| QGTSADEAFMVSPAQ | 236 | Q96JN8 | |
| GPMDNSLATSNTATE | 886 | Q96JN8 | |
| TAASEGRMVIQDIPA | 176 | Q9Y5R6 | |
| DTTANAEGDLPTTMG | 96 | Q08211 | |
| ETNTVEVITSAPGAM | 171 | Q7Z7J5 | |
| SIPVSVEAFLMQASG | 206 | Q7Z7J5 | |
| VLQSMATGATFPEEA | 11 | Q99574 | |
| TLTEERNAVMVPSAG | 1136 | Q9NQT8 | |
| EMEQSSGTGPAELTQ | 411 | Q8NHP6 | |
| DVPDGTLVTVMAGND | 96 | Q01196 | |
| AATNSTELGIMEPSS | 486 | Q5VT97 | |
| SPLNVIAEDGTMTSL | 411 | Q5ST30 | |
| EEAMNTTSLLAPAAE | 361 | C9JL84 | |
| LAAMEALSTEPSATE | 256 | Q14242 | |
| NMDSPTLQVTGSESI | 4446 | O75445 | |
| MATGVPADILTETIN | 321 | O60763 | |
| STAVLSPEDMSAQGS | 231 | Q8NB59 | |
| MESAEPAGQARAAAT | 1 | Q16572 | |
| GRAMTLSPQEEVAAG | 311 | Q9Y6A5 | |
| LSPQEEVAAGQMASS | 316 | Q9Y6A5 | |
| PSGNLAEESVGSEMV | 216 | Q5HYK7 | |
| GMTEISGDSSAIPQA | 306 | O75159 | |
| PSGMAEGATTTDVDA | 81 | Q2M2I3 | |
| PSDSLELMVSGAAET | 411 | O75019 | |
| PASMEITAGERNVTL | 1196 | O14513 | |
| TPIAVMGEFANLATS | 901 | P22670 | |
| NETAMESEALVGLPS | 226 | Q8WUX1 | |
| AEMIDALANSVTPAV | 796 | Q6P1X5 | |
| SVMVGSVTESLAPQA | 151 | Q9BXS9 | |
| PQGISMLDAEASFIT | 191 | Q06033 | |
| VDPVLADRSAAEMSG | 161 | A6NNJ1 | |
| AMTNTEIALPGEVSA | 2101 | Q96Q15 | |
| LPSGMLVISNATEGD | 201 | Q92859 | |
| NMGDTLDESSLTASP | 921 | Q9NZC9 | |
| ESIMAQVALGPAESS | 401 | Q8IUH8 | |
| DAMEVIPSTLAENAG | 456 | P50991 | |
| SLISMQGPVSELESA | 361 | Q8TE82 | |
| LAAATASILTNPMDV | 231 | Q96H78 | |
| VDTAMPASVITTQGL | 411 | Q6P9B9 | |
| NSLMAAGESPVETLA | 71 | Q6NSI8 | |
| PSAVAVAGSSSAEEM | 1201 | Q12769 | |
| MAATASAGVPATVSE | 1 | O60518 | |
| GQAMVAEASPTVDSF | 176 | Q92935 | |
| MVPVAQAGSSEASLA | 546 | Q14162 | |
| LDQAVGAAVTSMGPE | 531 | Q5JTH9 | |
| SALQSAGVVVSMSPA | 316 | P53597 | |
| SMEELDQTAQTLTGP | 1681 | Q9NRC6 | |
| FQVMADGSISTILPE | 1591 | Q6Q759 | |
| MSLQLPEADAEVTAS | 5246 | Q8IVF2 | |
| DGLMVATPAQTLTDT | 981 | Q8IWZ3 | |
| ISMAPSAEGGEEVLT | 786 | Q9NQW8 | |
| NDGQSSAIPVASMEF | 446 | Q9H9A5 | |
| DSLGAPEMTTTSIND | 841 | Q9BXT8 | |
| QAQASIEGAPEVTMS | 406 | Q6KCM7 | |
| NALFVIDTTPGMSAD | 486 | Q5QJE6 | |
| MAASEVAGVVANAPS | 1 | Q8ND24 | |
| MSEVEAAAGATAVPA | 1 | Q9Y2T7 | |
| SSLNMDEVSSVSVGP | 691 | P98169 | |
| VISSSPEDSGMGNDI | 446 | O95625 | |
| ATKMAAVTAPEAESA | 56 | Q9H322 | |
| EDPVLAMTDAGQSTE | 671 | O75970 | |
| AMTDAGQSTEEVQAP | 676 | O75970 | |
| SMIILQDSAPESGDA | 891 | Q9BYB0 | |
| NGETSPTVSMAELEH | 261 | P35398 | |
| LINTSEAGIPAMSTN | 321 | A6NJ88 | |
| PASITDMLLEGNVAS | 316 | Q8NE28 | |
| SEEELAAMSPTAAAV | 371 | P12270 | |
| TQAVAPDSSSEMGDL | 261 | P43119 | |
| PMDQVLATASADGTI | 531 | Q12788 | |
| MSVSGAETVNGEVPA | 246 | Q8IUW5 | |
| MAAAELTAPAQGIVT | 1 | Q9Y2P7 | |
| VLFVNSVDMESLTGP | 1601 | Q9HBL0 | |
| GSASVSMVLSVNVPD | 601 | Q92626 | |
| MAEASVDASTLPVTV | 1 | Q8IY51 | |
| LDTSASVGPENFAQM | 536 | Q5GFL6 | |
| DEMDTGDTINQSTLP | 421 | P46937 | |
| MSATVVDAVNAAPLS | 1 | O95391 | |
| TGSIDMVDSPQLATL | 731 | P10636 | |
| MVDSPQLATLADEVS | 736 | P10636 | |
| AQLTGRMPAAETTGE | 501 | O00534 | |
| ALDQTPGSSMDNLDS | 1236 | Q9HCK4 | |
| TTRGAAVSAEAMEPE | 86 | O14492 | |
| ASFEIPASAMEANGV | 2396 | O95359 | |
| TFNVLEVSGSMPDSL | 546 | O15040 | |
| MEVAELGFPETAVSQ | 1 | O75678 | |
| FVSLSAGENVLPSTM | 141 | Q6UWH6 | |
| IDLVLPNAGSTTGMT | 1661 | Q86WI1 | |
| PLMANDSTETSEAGE | 386 | Q9HCJ6 | |
| ATKMAAVTAPEAESA | 56 | Q9H320 | |
| MDNVSILSSQPEGSL | 2111 | Q8IUG5 | |
| SVVLGTNDLTSPSME | 121 | Q6UWB4 | |
| MEEEASRSAAATNPG | 1 | Q9H869 | |
| EPSNVTETLMGGVSL | 156 | P10073 | |
| PMGVQAREESSDSAE | 426 | Q8WYQ9 | |
| PTSGMAAAEAEAALS | 201 | Q13105 | |
| LQGVMAAEAGDLSTA | 56 | A6NLP5 | |
| PGVAETLVEAVSMSA | 76 | O14904 | |
| VLETAGTVAAMAATP | 21 | Q8WWH5 | |
| SEFMIQSPEAAGQEA | 456 | Q7Z403 | |
| VIPDDNQTDSGMVLA | 1251 | P35968 | |
| AMVVTGLAVSPDSSQ | 146 | Q8NA23 | |
| SQQSVMLGSLADAAP | 631 | Q9Y3S1 | |
| QESSSSLEMPSGVAL | 706 | P48553 | |
| AAIVGESMAALVTLP | 491 | Q9Y334 | |
| LAVQPEAAGSVAMEA | 761 | Q5H9R7 | |
| TPAVDALTSMVVLDA | 51 | Q6ZRP0 | |
| VDVMLNPGSATSNVA | 301 | Q8IYM9 | |
| NNELDTSLESMPASG | 336 | Q8IYH5 | |
| QDGTLLSNSISVMPD | 126 | O94900 | |
| VDMTLAVATETPGGS | 91 | Q68DY9 | |
| ELQESSVASAMELPG | 371 | P18583 | |
| APESSAMAVLESSAV | 1351 | P18583 | |
| SMDPDIQVHSLAVSG | 551 | P51854 | |
| EPAGMAAEVALSESA | 366 | Q6ZSZ6 | |
| LSVVSMLAEPNDESG | 121 | P60604 | |
| PATEGSMDTLENVQL | 196 | Q86VY4 | |
| VDPVLADRSAAEMSG | 161 | P0DV75 | |
| GSMSDSANILDEVPF | 176 | Q15049 | |
| ALGTQMSDPTSVAEL | 331 | Q92539 | |
| QMAATVPSRDSGEEA | 406 | Q00653 | |
| EAQEMPSQLFTLGAS | 416 | Q92692 |